Document:

EX-4.2

 Exhibit 4.2 

AMENDED AND RESTATED WARRANT AGREEMENT 

between 
 TRITIUM DCFC LIMITED,

 COMPUTERSHARE INC., 
 and

 COMPUTERSHARE TRUST COMPANY, N.A. 

THIS AMENDED AND RESTATED WARRANT AGREEMENT (this “Agreement”), dated as of January 13, 2022, is by and among
Tritium DCFC Limited, an Australian public company limited by shares (the “Company” or “DCFC”), Computershare Inc., a Delaware corporation (“Computershare”), and its affiliate,
Computershare Trust Company, N.A., a federally chartered trust company, (together with Computershare, collectively, the “Warrant Agent”). 

WHEREAS, in connection with the initial public offering (“DCRN IPO”) of units and simultaneous private placement of
warrants of Decarbonization Plus Acquisition Corporation II, a Delaware corporation (“DCRN”), DCRN engaged the Continental Stock Transfer & Trust Company, a New York corporation
(“Continental”) to act on behalf of DCRN in connection with the issuance, registration, transfer, exchange, redemption and exercise of DCRN’s warrants on the terms and conditions set forth in the Warrant Agreement, dated
as of February 3, 2021, between DCRN and Continental (the “Prior Agreement”); 
 WHEREAS, pursuant to the
Business Combination Agreement, dated as of May 25, 2021, as amended (as may be further amended from time to time, the “Business Combination Agreement”), by and among DCRN, DCFC, Hulk Merger Sub, Inc., a Delaware
corporation and wholly owned subsidiary of DCFC, and Tritium Holdings Pty Ltd, an Australian proprietary company limited by shares, the parties consummated a business combination on or about the date hereof (the “Business
Combination”); 
 WHEREAS, in connection with the Business Combination and pursuant to the Business Combination Agreement,
(i) each warrant to purchase shares of DCRN’s Class A Common Stock, including (a) 13,416,667 warrants sold to the public in the DCRN IPO (“DCRN Public Warrants”), (b) 7,366,667 warrants issued to
Decarbonization Plus Acquisition Sponsor II, LLC, a Delaware limited liability company (“DCRN Sponsor”), and certain of DCRN’s independent directors (each individually a “Purchaser” and,
collectively, the “Purchasers”) in connection with the DCRN IPO (collectively, the “DCRN Private Placement Warrants” and together with the DCRN Public Warrants, the “DCRN
Warrants”) and (c) 1,000,000 DCRN Private Placement Warrants issued to DCRN Sponsor pursuant to a working capital loan made by DCRN Sponsor to DCRN converted into warrants to purchase an equal number of ordinary shares in the capital of
DCFC (“DCFC Ordinary Shares”) (as converted, such DCRN Public Warrants being referred to as “Public Warrants,” such DCRN Private Placement Warrants being referred to as “Private Placement
Warrants” and such DCRN Warrants being referred to as “Warrants”); 
 WHEREAS, DCFC, DCRN, Continental,
Computershare and the Warrant Agent entered into that certain Assignment and Assumption Agreement (the “Assignment and Assumption Agreement”), dated on or about the date hereof, pursuant to which, in accordance with
Section 8.2 and Section 9.1 of the Prior Agreement, (i) DCFC was substituted for DCRN in the Prior Agreement and became obligated to perform all of the duties of DCRN under the Prior Agreement and (ii) the Warrant Agent was
substituted for Continental in the Prior Agreement and became obligated to perform all of the duties of Continental under the Prior Agreement; 

WHEREAS, for the purpose of curing any ambiguity as to whether the Prior Agreement applies to the Warrants following the Closing, DCFC and the
Warrant Agent agree that the Prior Agreement is hereby amended and restated in its entirety in accordance with the terms hereof pursuant to Section 9.8 of the Prior Agreement, and, with effect from and following the Closing, this Agreement
shall apply, and the terms of the Prior Agreement shall cease to apply, to the Warrants; and 

 WHEREAS, all acts and things have been done and performed which are necessary to make the
Warrants, when, if a physical certificate is issued, executed on behalf of the Company and countersigned by or on behalf of the Warrant Agent, as provided herein, the valid, binding and legal obligations of the Company, and to authorize the
execution and delivery of this Agreement. 
 NOW, THEREFORE, in consideration of the mutual agreements herein contained, the parties hereto
agree as follows: 
 1.    Appointment of Warrant Agent. The Company hereby appoints the Warrant Agent to act as
agent for the Company for the Warrants, and the Warrant Agent hereby accepts such appointment and agrees to perform the same in accordance with the express terms and conditions set forth in this Agreement. 

2.    Warrants. 

2.1    Form of Warrant. Each Warrant shall be issued in registered form only and initially issued in book-entry
form. 
 2.2    Effect of Countersignature. If a physical certificate is issued, unless and until countersigned
in manual, facsimile or other electronic form by the Warrant Agent pursuant to this Agreement, such physical certificated Warrant shall be invalid and of no effect and may not be exercised by the holder thereof. 

2.3    Registration. 

2.3.1    Warrant Register. The Warrant Agent shall maintain books (the “Warrant
Register”), for the registration of original issuance and the registration of transfer of the Warrants. Upon the initial issuance of the Warrants, the Warrant Agent shall issue and register the Warrants in the names of the
respective holders thereof in such denominations and otherwise in accordance with instructions delivered to the Warrant Agent by the Company. Ownership of beneficial interests in the Public Warrants shall be shown on, and the transfer of such
ownership shall be effected through, records maintained by institutions that have accounts with The Depository Trust Company (“DTC”) (such institution, with respect to a Warrant in its account, a
“Participant”).  
 If DTC ceases on or after the date hereof to make its book-entry settlement system
available for the Public Warrants, the Company may instruct the Warrant Agent regarding making other arrangements for book-entry settlement. In the event that the Public Warrants are not eligible for, or it is no longer necessary to have the Public
Warrants available in, book-entry form, the Warrant Agent shall provide written instructions to DTC to deliver to the Warrant Agent for cancellation each book-entry Public Warrant, and the Company shall instruct the Warrant Agent to deliver to DTC
definitive certificates in physical form evidencing such Warrants (“Definitive Warrant Certificates”) which shall be in the form annexed hereto as Exhibit A. 

Physical certificates, if issued, shall be signed by, or bear the facsimile signature of, the Chairman of the Board, Chief Executive Officer,
Chief Financial Officer, Secretary or other principal officer of the Company. In the event the person whose facsimile signature has been placed upon any Warrant shall have ceased to serve in the capacity in which such person signed the Warrant
before such Warrant is issued, it may be issued with the same effect as if he or she had not ceased to be such at the date of issuance. 

2.3.2    Registered Holder. Prior to due presentment for registration of transfer of any Warrant, the Company and
the Warrant Agent may deem and treat the person or entity in whose name such Warrant is registered in the Warrant Register (the “Registered Holder”) as the absolute owner of such Warrant and of each Warrant represented
thereby (notwithstanding any notation of ownership or other writing on any physical certificate made by anyone other than the Warrant Agent), for the purpose of any exercise thereof, and for all other purposes, and neither the Company nor the
Warrant Agent shall be affected by any notice to the contrary. 
 2.4    [Reserved.] 

  
 2 

 2.5    Fractional Warrants. The Company shall not issue
fractional Warrants. If a holder of Warrants would be entitled to receive a fractional Warrant, the Company shall round down to the nearest whole number the number of Warrants to be issued to such holder. 

2.6    Private Placement Warrants. The Private Placement Warrants shall be identical to the Public Warrants, except
that so long as they are held by the Purchasers or any of their Permitted Transferees (as defined below), the Private Placement Warrants: (i) may be exercised for cash or on a cashless basis, pursuant to subsection 3.3.1(c) hereof;
(ii) may not be transferred, assigned or sold until thirty (30) days after the date hereof; and (iii) shall not be redeemable by the Company; provided, however, that in the case of (ii), the Private Placement Warrants and any DCFC
Ordinary Shares held by a Purchaser or a Permitted Transferee and issued upon exercise of the Private Placement Warrants may be transferred by the holders thereof: 
  

	 	(a)	 to the Company’s officers or directors, any affiliates or family members of any of the Company’s
officers or directors, any member(s) of the DCRN Sponsor or any affiliates of the DCRN Sponsor; 

  

	 	(b)	 in the case of an individual, by gift to a member of the individual’s immediate family, to a trust, the
beneficiary of which is a member of the individual’s immediate family, or an affiliate of such person, or to a charitable organization; 

  

	 	(c)	 in the case of an individual, by virtue of laws of descent and distribution upon death of the individual;

  

	 	(d)	 in the case of an individual, pursuant to a qualified domestic relations order; 

 

	 	(e)	 by virtue of the laws of the state of Delaware or the DCRN Sponsor’s limited liability company agreement
upon dissolution of the DCRN Sponsor; 

  

	 	(f)	 in the event of the Company’s completion of a liquidation, merger, capital stock exchange, reorganization
or other similar transaction which results in all of the Company’s stockholders having the right to exchange their DCFC Ordinary Shares for cash, securities or other property; 

provided, however, that, in the case of clauses (a) through (e), these transferees (the “Permitted Transferees”)
must enter into a written agreement with the Company agreeing to be bound by the transfer restrictions in this Agreement. 

3.    Terms and Exercise of Warrants. 

3.1    Warrant Price. Each Warrant shall, when countersigned by the Warrant Agent, entitle the Registered Holder
thereof, subject to the provisions of such Warrant and of this Agreement, to purchase from the Company the number of DCFC Ordinary Shares stated therein, at the price of $11.50 per share, subject to the adjustments provided in Section 4 hereof
and in the penultimate sentence of this Section 3.1. The term “Warrant Price” as used in this Agreement shall mean the price per share at which DCFC Ordinary Shares may be purchased at the time a Warrant is exercised. The Company in
its sole discretion may lower the Warrant Price at any time prior to the Expiration Date (as defined below) for a period of not less than twenty (20) Business Days (as defined below), provided, that the Company shall provide at least twenty
(20) days prior written notice of such reduction to the Warrant Agent and Registered Holders of the Warrants and, provided further that any such reduction shall be identical among all of the Warrants. For the purposes of this Agreement, a
“Business Day” shall mean a day, other than a Saturday, Sunday or federal holiday, on which banks in New York City are generally open for normal business. 

3.2    Duration of Warrants. A Warrant may be exercised only during the period (the “Exercise
Period”) (A) commencing on February 12, 2022 and (B) terminating at 5:00 p.m., New York City time on the earlier to occur of: (x) the date that is five (5) years after the date hereof, and (y) other than with
respect to the Private Placement Warrants then held by the Purchasers or their Permitted Transferees (an “Inapplicable Redemption”), the 

  
 3 

 Redemption Date (as defined below) as provided in Section 6.3 hereof, or (z) the Alternative
Redemption Date (as defined below) as provided in Section 6.2 hereof (the “Expiration Date”); provided, however, that the exercise of any Warrant shall be subject to the satisfaction of any applicable conditions, as set
forth in subsection 3.3.2 below with respect to an effective registration statement. Except with respect to the right to receive the Redemption Price (as defined below) (other than with respect to an Inapplicable Redemption) in the event of a
redemption (as set forth in Section 6 hereof), each Warrant (other than a Private Placement Warrant then held by a Purchaser or a Permitted Transferee in the event of an Inapplicable Redemption) not exercised on or before the Expiration Date
shall become void, and all rights thereunder and all rights in respect thereof under this Agreement shall cease at 5:00 p.m. New York City time on the Expiration Date. The Company in its sole discretion may extend the duration of the Warrants by
delaying the Expiration Date; provided, that the Company shall provide at least twenty (20) days prior written notice of any such extension to the Warrant Agent and Registered Holders of the Warrants and, provided further that any such
extension shall be identical in duration among all the Warrants. 
 3.3    Exercise of Warrants. 

3.3.1    Payment. Subject to the provisions of the Warrant and this Agreement, a Warrant, when countersigned by
the Warrant Agent, may be exercised by the Registered Holder thereof by surrendering it, at the office designated for such purpose, (i) the Definitive Warrant Certificate evidencing the Warrants to be exercised, or, in the case of a Warrant in
book-entry form, the Warrants to be exercised on the records of DTC to an account of the Warrant Agent at DTC designated for such purposes in writing by the Warrant Agent to DTC from time to time, (ii) an election to purchase (as set forth on
the Warrant ) any DCFC Ordinary Shares pursuant to the exercise of a Warrant, properly completed and duly executed by the Registered Holder on the reverse of the Definitive Warrant Certificate accompanied by a signature guarantee or, in the case of
a Warrant in book-entry form, properly delivered by the Participant in accordance with DTC’s procedures, and (iii) the payment in full the Warrant Price for each full DCFC Ordinary Share as to which the Warrant is exercised and any and all
applicable taxes due in connection with the exercise of the Warrant, the exchange of the Warrant for the DCFC Ordinary Shares and the issuance of such DCFC Ordinary Shares, as follows: 

(a)    in lawful money of the United States, in good certified check or good bank draft payable to the Warrant Agent;

 (b)    [reserved]; 

(c)    with respect to any Private Placement Warrant, so long as such Private Placement Warrant is held by a Purchaser or
a Permitted Transferee, by surrendering the Warrants for that number of DCFC Ordinary Shares equal to the quotient obtained by dividing (x) the product of the number of DCFC Ordinary Shares underlying the Warrants, multiplied by the difference
between the Warrant Price and the “Fair Market Value”, as defined in this subsection 3.3.1(c), by (y) the Fair Market Value. Solely for purposes of this subsection 3.3.1(c), the “Fair Market Value” shall mean the average
reported last sale price of the DCFC Ordinary Shares for the ten (10) trading days ending on the third trading day prior to the date on which notice of exercise of the Private Placement Warrant is sent to the Warrant Agent; 

(d)    as provided in Section 6.2 hereof with respect to a Make-Whole Exercise; or 

(e)    as provided in Section 7.4 hereof. 

3.3.2    Issuance of DCFC Ordinary Shares on Exercise. As soon as practicable after the exercise of any Warrant
and the clearance of the funds in payment of the Warrant Price (if payment is pursuant to subsection 3.3.1(a)), the Company shall issue to the Registered Holder of such Warrant a book-entry position or certificate, as applicable, for the number of
full DCFC Ordinary Shares to which he, she or it is entitled, registered in such name or names as may be directed by him, her or it, and if such Warrant shall not have been exercised in full, a new book-entry position or countersigned Warrant, as
applicable, for the number of DCFC Ordinary Shares as to which such Warrant shall not have been exercised. Notwithstanding the foregoing, the Company shall not be obligated to deliver any DCFC Ordinary Shares pursuant to the exercise of a Warrant
and shall have no obligation to settle such Warrant exercise unless a registration statement under the Securities Act with respect to the DCFC Ordinary Shares underlying the Public Warrants is then effective and a prospectus relating thereto is
current, subject 

  
 4 

 
to the Company’s satisfying its obligations under Section 7.4. No Warrant shall be exercisable and the Company shall not be obligated to issue DCFC Ordinary Shares upon exercise of a
Warrant unless the DCFC Ordinary Shares issuable upon such Warrant exercise has been registered, qualified or deemed to be exempt from registration or qualification under the securities laws of the state of residence of the Registered Holder of the
Warrants. In the event that the conditions in the two immediately preceding sentences are not satisfied with respect to a Warrant, the holder of such Warrant shall not be entitled to exercise such Warrant and such Warrant may have no value and
expire worthless, in which case the purchaser of a Unit containing such Public Warrants shall have paid the full purchase price for the Unit solely for the DCFC Ordinary Shares underlying such Unit. In no event will the Company be required to net
cash settle the Warrant exercise. The Company may require holders of Public Warrants to settle the Warrant on a “cashless basis” pursuant to Section 7.4. If, by reason of any exercise of Warrants on a “cashless basis”, the
holder of such Warrant would be entitled, upon the exercise of such Warrant, to receive a fractional interest in a DCFC Ordinary Share, the Company shall round down to the nearest whole number the number of DCFC Ordinary Shares to be issued to such
holder. The Company shall calculate and transmit to the Warrant Agent, and the Warrant Agent shall have no obligation under this Agreement to calculate, such fractional interest. The number of DCFC Ordinary Shares to be issued on such exercise will
be determined by the Company (with written notice thereof to the Warrant Agent) and the Warrant Agent shall have no duty or obligation to investigate or confirm whether the Company’s determination of the number of DCFC Ordinary Shares to be
issued on such exercise, is accurate or correct. 
 3.3.3    Valid Issuance. All DCFC Ordinary Shares issued
upon the proper exercise of a Warrant in conformity with this Agreement shall be validly issued, fully paid and non-assessable. 

3.3.4    Date of Issuance. Each person or entity in whose name any book-entry position or certificate, as
applicable, for DCFC Ordinary Shares is issued shall for all purposes be deemed to have become the holder of record of such DCFC Ordinary Shares on the date on which the Warrant, or book-entry position representing such Warrant, was surrendered and
payment of the Warrant Price was made, irrespective of the date of delivery of such certificate in the case of a certificated Warrant, except that, if the date of such surrender and payment is a date when the share transfer books of the Company or
book-entry system of the Warrant Agent are closed, such person or entity shall be deemed to have become the holder of such DCFC Ordinary Shares at the close of business on the next succeeding date on which the share transfer books or book-entry
system are open. 
 3.3.5    Maximum Percentage. A holder of a Warrant may notify the Company in writing in the
event it elects to be subject to the provisions contained in this subsection 3.3.5; however, no holder of a Warrant shall be subject to this subsection 3.3.5 unless he, she or it makes such election. If the election is made by a holder, the Warrant
Agent shall not effect the exercise of the holder’s Warrant, and such holder shall not have the right to exercise such Warrant, to the extent that after giving effect to such exercise, such person (together with such person’s affiliates),
to the Warrant Agent’s actual knowledge, would beneficially own in excess of 9.8% or such other amount as the holder may specify (the “Maximum Percentage”) of the DCFC Ordinary Shares outstanding immediately after giving
effect to such exercise. For purposes of the foregoing sentence, the aggregate number of DCFC Ordinary Shares beneficially owned by such person and its affiliates shall include the number of DCFC Ordinary Shares issuable upon exercise of the Warrant
with respect to which the determination of such sentence is being made, but shall exclude DCFC Ordinary Shares that would be issuable upon (x) exercise of the remaining, unexercised portion of the Warrant beneficially owned by such person and
its affiliates and (y) exercise or conversion of the unexercised or unconverted portion of any other securities of the Company beneficially owned by such person and its affiliates (including, without limitation, any convertible notes or
convertible preferred stock or warrants) subject to a limitation on conversion or exercise analogous to the limitation contained herein. Except as set forth in the preceding sentence, for purposes of this paragraph, beneficial ownership shall be
calculated in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). For purposes of the Warrant, in determining the number of outstanding DCFC Ordinary Shares, the holder
may rely on the number of outstanding DCFC Ordinary Shares as reflected in (1) the Company’s most recent Annual Report on Form 20-F, Current Report on Form 6-K
or other public filing with the Securities and Exchange Commission (the “Commission”) as the case may be, (2) a more recent public announcement by the Company or (3) any other notice by the Company or Computershare
Inc. and Computershare Trust Company, N.A., joingly, in their capacity as the transfer agent for the DCFC Ordinary Shares (the “Transfer Agent”) setting forth the number of DCFC Ordinary Shares outstanding. For any reason at
any time, upon the written request of the holder of the Warrant, the Company shall, within two (2) Business Days, confirm orally and in writing to such holder the number of DCFC Ordinary 

  
 5 

 
Shares then outstanding. In any case, the number of outstanding DCFC Ordinary Shares shall be determined after giving effect to the conversion or exercise of equity securities of the Company by
the holder and its affiliates since the date as of which such number of outstanding DCFC Ordinary Shares was reported. By written notice to the Company, the holder of a Warrant may from time to time increase or decrease the Maximum Percentage
applicable to such holder to any other percentage specified in such notice; provided, however, that any such increase shall not be effective until the sixty-first (61st) day after such notice is delivered to the Company. 

4.    Adjustments. 

4.1    Stock Dividends. 

4.1.1    Split-Ups. If after the date hereof, and subject to the
provisions of Section 4.6 below, the number of outstanding DCFC Ordinary Shares is increased by a stock dividend payable in DCFC Ordinary Shares, or by a split-up of DCFC Ordinary Shares or other similar
event, then, on the effective date of such stock dividend, split-up or similar event, the number of DCFC Ordinary Shares issuable on exercise of each Warrant shall be increased in proportion to such increase
in the outstanding DCFC Ordinary Shares. A rights offering to holders of the Common Stock entitling holders to purchase DCFC Ordinary Shares at a price less than the “Fair Market Value” (as defined below) shall be deemed a stock dividend
of a number of DCFC Ordinary Shares equal to the product of (i) the number of DCFC Ordinary Shares actually sold in such rights offering (or issuable under any other equity securities sold in such rights offering that are convertible into or
exercisable for the Common Stock) multiplied by (ii) one (1) minus the quotient of (x) the price per DCFC Ordinary Share paid in such rights offering divided by (y) the Fair Market Value. For purposes of this subsection 4.1.1, (i) if
the rights offering is for securities convertible into or exercisable for Common Stock, in determining the price payable for Common Stock, there shall be taken into account any consideration received for such rights, as well as any additional amount
payable upon exercise or conversion and (ii) “Fair Market Value” means the volume weighted average price of the Common Stock as reported during the ten (10) trading day period ending on the trading day prior to the first date on which
the DCFC Ordinary Shares trade on the applicable exchange or in the applicable market, regular way, without the right to receive such rights. 

4.1.2    Extraordinary Dividends. If the Company, at any time while the Warrants are outstanding and unexpired,
shall pay a dividend or make a distribution in cash, securities or other assets to the holders of the Common Stock on account of such DCFC Ordinary Shares (or other shares of the Company’s capital stock into which the Warrants are convertible),
other than (a) as described in subsection 4.1.1 above and (b) Ordinary Cash Dividends (as defined below) (any such non-excluded event being referred to herein as an “Extraordinary
Dividend”), then the Warrant Price shall be decreased, effective immediately after the effective date of such Extraordinary Dividend, by the amount of cash and/or the fair market value (as determined by the Company’s board of
directors (the “Board”), in good faith) of any securities or other assets paid on each DCFC Ordinary Share in respect of such Extraordinary Dividend. For purposes of this subsection 4.1.2, “Ordinary Cash
Dividends” means any cash dividend or cash distribution which, when combined on a per share basis, with the per share amounts of all other cash dividends and cash distributions paid on the Common Stock during the 365-day period ending on the date of declaration of such dividend or distribution (as adjusted to appropriately reflect any of the events referred to in other subsections of this Section 4 and excluding cash
dividends or cash distributions that resulted in an adjustment to the Warrant Price or to the number of DCFC Ordinary Shares issuable on exercise of each Warrant) does not exceed $0.50. 

4.2    Aggregation of Shares. If after the date hereof, and subject to the provisions of Section 4.6 hereof, the
number of outstanding DCFC Ordinary Shares are decreased by a consolidation, combination, reverse stock split or reclassification of DCFC Ordinary Shares or other similar event, then, on the effective date of such consolidation, combination, reverse
stock split, reclassification or similar event, the number of DCFC Ordinary Shares issuable on exercise of each Warrant shall be decreased in proportion to such decrease in outstanding DCFC Ordinary Shares. 

4.3    Adjustments in Exercise and Redemption Trigger Prices. Whenever the number of DCFC Ordinary Shares
purchasable upon the exercise of the Warrants is adjusted, as provided in subsection 4.1.1 or Section 4.2 above, the Warrant Price shall be adjusted (to the nearest cent) by multiplying such Warrant Price immediately prior to such adjustment by
a fraction (x) the numerator of which shall be the number of DCFC Ordinary Shares purchasable upon the exercise of the Warrants immediately prior to such adjustment, and (y) the denominator of which shall be the number of DCFC Ordinary
Shares so purchasable immediately thereafter. 

  
 6 

 4.4     Replacement of Securities upon Reorganization, etc. In
case of any reclassification or reorganization of the outstanding DCFC Ordinary Shares (other than a change under subsections 4.1.1 or 4.1.2 or Section 4.2 hereof or that solely affects the par value of such DCFC Ordinary Shares), or in the
case of any merger or consolidation of the Company with or into another corporation or other entity (other than a consolidation or merger in which the Company is the continuing corporation and that does not result in any reclassification or
reorganization of the outstanding DCFC Ordinary Shares), or in the case of any sale or conveyance to another corporation or entity of the assets or other property of the Company as an entirety or substantially as an entirety in connection with which
the Company is dissolved, the holders of the Warrants shall thereafter have the right to purchase and receive, upon the basis and upon the terms and conditions specified in the Warrants and in lieu of the DCFC Ordinary Shares of the Company
immediately theretofore purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount of shares of stock or other securities or property (including cash) receivable upon such reclassification, reorganization,
merger or consolidation, or upon a dissolution following any such sale or transfer, that the holder of the Warrants would have received if such holder had exercised his, her or its Warrant(s) immediately prior to such event (the
“Alternative Issuance” ); provided, however, that (i) if the holders of the DCFC Ordinary Shares were entitled to exercise a right of election as to the kind or amount of securities, cash or other assets receivable upon
such consolidation or merger, then the kind and amount of securities, cash or other assets constituting the Alternative Issuance for which each Warrant shall become exercisable shall be deemed to be the weighted average of the kind and amount
received per share by the holders of the DCFC Ordinary Shares in such consolidation or merger that affirmatively make such election, and (ii) if a tender, exchange or redemption offer shall have been made to and accepted by the holders of the
DCFC Ordinary Shares under circumstances in which, upon completion of such tender or exchange offer, the maker thereof, together with members of any group (within the meaning of Rule 13d-5(b)(1) under the
Exchange Act (or any successor rule)) of which such maker is a part, and together with any affiliate or associate of such maker (within the meaning of Rule 12b-2 under the Exchange Act (or any successor rule))
and any members of any such group of which any such affiliate or associate is a part, own beneficially (within the meaning of Rule 13d-3 under the Exchange Act (or any successor rule)) more than 50% of the
outstanding DCFC Ordinary Shares, the holder of a Warrant shall be entitled to receive as the Alternative Issuance, the highest amount of cash, securities or other property to which such holder would actually have been entitled as a stockholder if
such Warrant holder had exercised the Warrant prior to the expiration of such tender or exchange offer, accepted such offer and all of the DCFC Ordinary Shares held by such holder had been purchased pursuant to such tender or exchange offer, subject
to adjustments (from and after the consummation of such tender or exchange offer) as nearly equivalent as possible to the adjustments provided for in this Section 4; provided, further, that if less than 70% of the consideration receivable by
the holders of the DCFC Ordinary Shares in the applicable event is payable in the form of common stock in the successor entity that is listed for trading on a national securities exchange or is quoted in an established
over-the-counter market, or is to be so listed for trading or quoted immediately following such event, and if the Registered Holder properly exercises the Warrant within
thirty (30) days following the public disclosure of the consummation of such applicable event by the Company pursuant to a Current Report on Form 6-K filed with the Commission, the Warrant Price shall be
reduced by an amount (in dollars) equal to the difference of (i) the Warrant Price in effect prior to such reduction minus (ii) (A) the Per Share Consideration (as defined below) (but in no event less than zero) minus (B) the
Black-Scholes Warrant Value (as defined below). The “Black-Scholes Warrant Value” means the value of a Warrant immediately prior to the consummation of the applicable event based on the Black-Scholes Warrant Model for a
Capped American Call on Bloomberg Financial Markets (“Bloomberg”). For purposes of calculating such amount, (1) Section 6 of this Agreement shall be taken into account, (2) the price of each DCFC Ordinary Share
shall be the volume weighted average price of the DCFC Ordinary Shares as reported during the ten (10) trading day period ending on the trading day prior to the effective date of the applicable event, (3) the assumed volatility shall be
the 90 day volatility obtained from the HVT function on Bloomberg determined as of the trading day immediately prior to the day of the announcement of the applicable event, and (4) the assumed risk-free interest rate shall correspond to the
U.S. Treasury rate for a period equal to the remaining term of the Warrant. “Per Share Consideration” means (i) if the consideration paid to holders of the DCFC Ordinary Shares consists exclusively of cash, the amount of
such cash per DCFC Ordinary Share, and (ii) in all other cases, the volume weighted average price of the DCFC Ordinary Shares as reported during the ten (10) trading day period ending on the trading day prior to the effective date of the
applicable event. If any reclassification or reorganization also results in a change in DCFC Ordinary Shares covered by subsection 4.1.1, then such adjustment shall be made pursuant to subsection 4.1.1 or Sections 4.2, 4.3 and this 

  
 7 

 
Section 4.4. The provisions of this Section 4.4 shall similarly apply to successive reclassifications, reorganizations, mergers or consolidations, sales or other transfers. In no event
will the Warrant Price be reduced to less than the par value per share issuable upon exercise of the Warrant. 
 4.5
    Notices of Changes in Warrant. Upon every adjustment of the Warrant Price or the number of DCFC Ordinary Shares issuable upon exercise of a Warrant, the Company shall give written notice thereof to the Warrant Agent,
which notice shall state the Warrant Price resulting from such adjustment and the increase or decrease, if any, in the number of DCFC Ordinary Shares purchasable at such price upon the exercise of a Warrant, setting forth in reasonable detail the
method of calculation and the facts upon which such calculation is based. Upon the occurrence of any event specified in Sections 4.1, 4.2, 4.3 or 4.4, the Company shall give written notice of the occurrence of such event to each holder of a Warrant,
at the last address set forth for such holder in the Warrant Register, of the record date or the effective date of the event. Failure to give such notice, or any defect therein, shall not affect the legality or validity of such event. The Warrant
Agent shall be fully protected in relying on any such notice and on any adjustment therein contained and shall have no duty or liability with respect to, and shall not be deemed to have knowledge of, such adjustment unless and until it shall have
received such notice. 
 4.6     No Fractional Shares. Notwithstanding any provision contained in this Agreement
to the contrary, the Company shall not issue fractional DCFC Ordinary Shares upon the exercise of Warrants. If, by reason of any adjustment made pursuant to this Section 4, the holder of any Warrant would be entitled, upon the exercise of such
Warrant, to receive a fractional interest in a share, the Company shall, upon such exercise, round down to the nearest whole number the number of DCFC Ordinary Shares to be issued to such holder. 

4.7     Form of Warrant. The form of Warrant need not be changed because of any adjustment pursuant to this
Section 4, and Warrants issued after such adjustment may state the same Warrant Price and the same number of DCFC Ordinary Shares as is stated in the Warrants initially issued pursuant to this Agreement; provided, however, that the Company may
at any time in its sole discretion make any change in the form of Warrant that the Company may deem appropriate and that does not affect the substance thereof, and any Warrant thereafter issued or countersigned, whether in exchange or substitution
for an outstanding Warrant or otherwise, may be in the form as so changed. 
 4.8     Other Events. In case any
event shall occur affecting the Company as to which none of the provisions of the preceding subsections of this Section 4 are strictly applicable, but which would require an adjustment to the terms of the Warrants in order to (i) avoid an
adverse impact on the Warrants and (ii) effectuate the intent and purpose of this Section 4, then, in each such case, the Company shall appoint a firm of independent public accountants, investment banking or other appraisal firm of
recognized national standing, which shall give its opinion as to whether or not any adjustment to the rights represented by the Warrants is necessary to effectuate the intent and purpose of this Section 4 and, if they determine that an
adjustment is necessary, the terms of such adjustment. The Company shall adjust the terms of the Warrants in a manner that is consistent with any adjustment recommended in such opinion. 

5.     Transfer and Exchange of Warrants. 

5.1     Registration of Transfer. The Warrant Agent shall register the transfer, from time to time, of any
outstanding Warrant upon the Warrant Register, upon surrender of such Warrant for transfer, properly endorsed with signatures properly guaranteed and accompanied by appropriate instructions for transfer. Upon any such transfer, a new Warrant
representing an equal aggregate number of Warrants shall be issued and the old Warrant shall be cancelled by the Warrant Agent. The Warrants so cancelled shall be delivered by the Warrant Agent to the Company from time to time upon request. 

5.2     Procedure for Surrender of Warrants. Warrants may be surrendered to the Warrant Agent, together with a
written request for exchange or transfer, and thereupon the Warrant Agent shall issue in exchange therefor one or more new Warrants as requested by the Registered Holder of the Warrants so surrendered, representing an equal aggregate number of
Warrants; provided, however, that in the event that a Warrant surrendered for transfer bears a restrictive legend (as in the case of the Private Placement Warrants), the Warrant Agent shall not cancel such Warrant and issue new Warrants in exchange
thereof until the Warrant Agent has received an opinion of counsel for the Company stating that such transfer may be made and indicating whether the new Warrants must also bear a restrictive legend. 

  
 8 

 5.3     Transfers of Fractions of Warrants. The Warrant Agent
shall not be required to effect any registration of transfer or exchange of Warrants which would require the issuance of a warrant certificate or book-entry position for a fraction of a warrant. 

5.4     Service Charges. No service charge shall be made for any exchange or registration of transfer of Warrants.

 5.5     Warrant Execution and Countersignature. The Warrant Agent is hereby authorized to countersign and to
deliver, in accordance with the terms of this Agreement, the Warrants required to be issued pursuant to the provisions of this Section 5, and the Company, whenever required by the Warrant Agent, shall supply the Warrant Agent with Warrants duly
executed on behalf of the Company for such purpose. 
 6.     Redemption. 

6.1     Redemption of Warrants for Cash When the Price Per DCFC Ordinary Share Equals or Exceeds $18.00. Subject to
Section 6.5 hereof, not less than all of the outstanding Warrants may be redeemed, at the option of the Company, at any time while they are exercisable and prior to their expiration, at the office of the Warrant Agent, upon notice to the
Registered Holders of the Warrants, as described in Section 6.3 below, at a Redemption Price of $0.01 per Warrant, provided that the last sale price of the DCFC Ordinary Shares reported has been at least $18.00 per share (subject to adjustment
in compliance with Section 4 hereof), on each of twenty (20) trading days within the thirty (30) trading-day period ending on the third Business Day prior to the date on which notice of the
redemption is given and provided that there is an effective registration statement covering the DCFC Ordinary Shares issuable upon exercise of the Warrants, and a current prospectus relating thereto, available throughout the 30-day Redemption Period (as defined in Section 6.3 below). 
 6.2
    Redemption of Warrants When the Price Per DCFC Ordinary Share Equals or Exceeds $10.00. Subject to Section 6.5 hereof, not less than all of the outstanding Warrants may be redeemed, at the option of the Company,
at any time while they are exercisable and prior to their expiration, at the office of the Warrant Agent, upon notice to the Registered Holders of the Warrants, as described in Section 6.3 below, at a Redemption Price of $0.10 per Warrant,
provided that the last sale price of the DCFC Ordinary Shares equals or exceeds $10.00 per share (subject to adjustment in compliance with Section 4 hereof), on the trading day prior to the date on which notice of the redemption is given.
During the 30-day Redemption Period (as defined in Section 6.3 below) in connection with a redemption pursuant to this Section 6.2, Registered Holders of the Warrants may elect to exercise their
Warrants on a “cashless basis” pursuant to subsection 3.3.1 and receive a number of DCFC Ordinary Shares determined by reference to the table below, based on the Redemption Date (as defined below) and the “Redemption Fair Market
Value” (as such term is defined in this Section 6.2) (a “Make-Whole Exercise”). Solely for purposes of this Section 6.2, the “Redemption Fair Market Value” shall mean the average reported last sale
price of the DCFC Ordinary Shares for the ten trading days immediately following the date on which notice of redemption pursuant to this Section 6.2 is sent to the Registered Holders. In connection with any redemption pursuant to this
Section 6.2, the Company shall provide the Registered Holders with the Redemption Fair Market Value no later than one Business Day after the ten (10) trading day period described in the definition of “Redemption Fair Market
Value” above ends. 
  

																																					
	 	  	Redemption Fair Market Value of DCFC Ordinary Shares	 
	 Redemption Date
(period to expiration of warrants)
	  	£10.00	 	  	11.00	 	  	12.00	 	  	13.00	 	  	14.00	 	  	15.00	 	  	16.00	 	  	17.00	 	  	318.00	 
	 60 months
	  	 	0.261	 	  	 	0.281	 	  	 	0.297	 	  	 	0.311	 	  	 	0.324	 	  	 	0.337	 	  	 	0.348	 	  	 	0.358	 	  	 	0.361	 
	 57 months
	  	 	0.257	 	  	 	0.277	 	  	 	0.294	 	  	 	0.310	 	  	 	0.324	 	  	 	0.337	 	  	 	0.348	 	  	 	0.358	 	  	 	0.361	 
	 54 months
	  	 	0.252	 	  	 	0.272	 	  	 	0.291	 	  	 	0.307	 	  	 	0.322	 	  	 	0.335	 	  	 	0.347	 	  	 	0.357	 	  	 	0.361	 
	 51 months
	  	 	0.246	 	  	 	0.268	 	  	 	0.287	 	  	 	0.304	 	  	 	0.320	 	  	 	0.333	 	  	 	0.346	 	  	 	0.357	 	  	 	0.361	 

  
 9 

																																					
	 48 months
	  	 	0.241	 	  	 	0.263	 	  	 	0.283	 	  	 	0.301	 	  	 	0.317	 	  	 	0.332	 	  	 	0.344	 	  	 	0.356	 	  	 	0.361	 
	 45 months
	  	 	0.235	 	  	 	0.258	 	  	 	0.279	 	  	 	0.298	 	  	 	0.315	 	  	 	0.330	 	  	 	0.343	 	  	 	0.356	 	  	 	0.361	 
	 42 months
	  	 	0.228	 	  	 	0.252	 	  	 	0.274	 	  	 	0.294	 	  	 	0.312	 	  	 	0.328	 	  	 	0.342	 	  	 	0.355	 	  	 	0.361	 
	 39 months
	  	 	0.221	 	  	 	0.246	 	  	 	0.269	 	  	 	0.290	 	  	 	0.309	 	  	 	0.325	 	  	 	0.340	 	  	 	0.354	 	  	 	0.361	 
	 36 months
	  	 	0.213	 	  	 	0.239	 	  	 	0.263	 	  	 	0.285	 	  	 	0.305	 	  	 	0.323	 	  	 	0.339	 	  	 	0.353	 	  	 	0.361	 
	 33 months
	  	 	0.205	 	  	 	0.232	 	  	 	0.257	 	  	 	0.280	 	  	 	0.301	 	  	 	0.320	 	  	 	0.337	 	  	 	0.352	 	  	 	0.361	 
	 30 months
	  	 	0.196	 	  	 	0.224	 	  	 	0.250	 	  	 	0.274	 	  	 	0.297	 	  	 	0.316	 	  	 	0.335	 	  	 	0.351	 	  	 	0.361	 
	 27 months
	  	 	0.185	 	  	 	0.214	 	  	 	0.242	 	  	 	0.268	 	  	 	0.291	 	  	 	0.313	 	  	 	0.332	 	  	 	0.350	 	  	 	0.361	 
	 24 months
	  	 	0.173	 	  	 	0.204	 	  	 	0.233	 	  	 	0.260	 	  	 	0.285	 	  	 	0.308	 	  	 	0.329	 	  	 	0.348	 	  	 	0.361	 
	 21 months
	  	 	0.161	 	  	 	0.193	 	  	 	0.223	 	  	 	0.252	 	  	 	0.279	 	  	 	0.304	 	  	 	0.326	 	  	 	0.347	 	  	 	0.361	 
	 18 months
	  	 	0.146	 	  	 	0.179	 	  	 	0.211	 	  	 	0.242	 	  	 	0.271	 	  	 	0.298	 	  	 	0.322	 	  	 	0.345	 	  	 	0.361	 
	 15 months
	  	 	0.130	 	  	 	0.164	 	  	 	0.197	 	  	 	0.230	 	  	 	0.262	 	  	 	0.291	 	  	 	0.317	 	  	 	0.342	 	  	 	0.361	 
	 12 months
	  	 	0.111	 	  	 	0.146	 	  	 	0.181	 	  	 	0.216	 	  	 	0.250	 	  	 	0.282	 	  	 	0.312	 	  	 	0.339	 	  	 	0.361	 
	 9 months
	  	 	0.090	 	  	 	0.125	 	  	 	0.162	 	  	 	0.199	 	  	 	0.237	 	  	 	0.272	 	  	 	0.305	 	  	 	0.336	 	  	 	0.361	 
	 6 months
	  	 	0.065	 	  	 	0.099	 	  	 	0.137	 	  	 	0.178	 	  	 	0.219	 	  	 	0.259	 	  	 	0.296	 	  	 	0.331	 	  	 	0.361	 
	 3 months
	  	 	0.034	 	  	 	0.065	 	  	 	0.104	 	  	 	0.150	 	  	 	0.197	 	  	 	0.243	 	  	 	0.286	 	  	 	0.326	 	  	 	0.361	 
	 0 months
	  	 	—  	 	  	 	—  	 	  	 	0.042	 	  	 	0.115	 	  	 	0.179	 	  	 	0.233	 	  	 	0.281	 	  	 	0.323	 	  	 	0.361	 

 If the exact Redemption Fair Market Value and Redemption Date (as defined below) are between two values in the
table above or the Redemption Date is between two redemption dates in the table above, the number of DCFC Ordinary Shares to be issued for each Warrant exercised in a Make-Whole Exercise shall be determined by a straight-line interpolation between
the number of shares set forth for the higher and lower Redemption Fair Market Values and the earlier and later redemption dates, as applicable, based on a 365-day year. 

The stock prices set forth in the column headings of the table above shall be adjusted as of any date on which the number of shares issuable
upon exercise of a Warrant is adjusted pursuant to Section 4. The adjusted stock prices in the column headings shall equal the stock prices immediately prior to such adjustment, multiplied by a fraction, the numerator of which is the number of
shares deliverable upon exercise of a Warrant immediately prior to such adjustment and the denominator of which is the number of shares deliverable upon exercise of a Warrant as so adjusted. The number of shares in the table above shall be adjusted
in the same manner and at the same time as the number of shares issuable upon exercise of a Warrant. 
 In no event shall the Warrants be
exercisable in connection with a Make-Whole Exercise for more than 0.361 DCFC Ordinary Shares per whole warrant (subject to adjustment). 

6.3    Date Fixed for, and Notice of, Redemption; Redemption Price. In the event that the Company elects to redeem
the Warrants pursuant to Sections 6.1 or 6.2 hereof, the Company shall fix a date for the redemption (the “Redemption Date”). Notice of redemption shall be transmitted (including, if applicable, through the facilities of DTC)
and/or mailed (by first class mail, postage prepaid), by the Company not less than thirty (30) days prior to the Redemption Date (the “30-day Redemption Period”) to the Registered
Holders of the Warrants to be redeemed at their last addresses as they shall appear on the registration books. Any notice transmitted or mailed in the manner herein provided shall be conclusively presumed to have been duly given whether or not the
Registered Holder received such notice. As used in this Agreement, “Redemption Price” shall mean the price per Warrant at which any Warrants are redeemed pursuant to Sections 6.1 or 6.2 hereof. 

  
 10 

 6.4    Exercise After Notice of Redemption. The Warrants may be
exercised, for cash (or, if in connection with a redemption pursuant to Section 6.2 hereof, on a “cashless basis” in accordance with such section) at any time after notice of redemption shall have been given by the Company pursuant to
Section 6.3 hereof and prior to the Redemption Date. On and after the Redemption Date, the record holder of the Warrants shall have no further rights except to receive, upon surrender of the Warrants, the Redemption Price. 

6.5    Exclusion of Private Placement Warrants. The Company agrees that the redemption rights provided in Sections
6.1 and 6.2 hereof shall not apply to the Private Placement Warrants if at the time of the redemption such Private Placement Warrants continue to be held by the Purchasers or their Permitted Transferees. However, once such Private Placement Warrants
are transferred (other than to Permitted Transferees under Section 2.6 hereof), the Company may redeem the Private Placement Warrants pursuant to Section 6.1 or 6.2 hereof, provided that the criteria for redemption are met, including the
opportunity of the holder of such Private Placement Warrants to exercise the Private Placement Warrants prior to redemption pursuant to Section 6.4 hereof. Private Placement Warrants that are transferred to persons other than Permitted
Transferees shall upon such transfer cease to be Private Placement Warrants and shall become Public Warrants under this Agreement. 

7.    Other Provisions Relating to Rights of Holders of Warrants. 

7.1    No Rights as Stockholder. A Warrant does not entitle the Registered Holder thereof to any of the rights of
stockholders of the Company, including, without limitation, the right to receive dividends, or other distributions, exercise any preemptive rights to vote or to consent or to receive notice as a stockholder in respect of the meetings of stockholders
or the election of directors of the Company or any other matter. 
 7.2    Lost, Stolen, Mutilated, or Destroyed
Warrants. If any Warrant is lost, stolen, mutilated, or destroyed, the Company and the Warrant Agent may on such terms as to indemnity or otherwise as they may in their discretion impose (which shall, in the case of a mutilated Warrant, include
the surrender thereof), issue a new Warrant of like denomination, tenor, and date as the Warrant so lost, stolen, mutilated, or destroyed. Any such new Warrant shall constitute a substitute contractual obligation of the Company, whether or not the
allegedly lost, stolen, mutilated, or destroyed Warrant shall be at any time enforceable by anyone. 

7.3    Reservation of DCFC Ordinary Shares. The Company shall at all times reserve and keep available a number of
its authorized but unissued DCFC Ordinary Shares that shall be sufficient to permit the exercise in full of all outstanding Warrants issued pursuant to this Agreement. 

7.4    Registration of DCFC Ordinary Shares; Cashless Exercise at Company’s Option. 

7.4.1    Registration of the DCFC Ordinary Shares Underlying Public Warrants and Private Placement Warrants. On
December 20, 2021, the registration statement on Form F-4 (Commission File No. 333-259793) registering the DCFC Ordinary Shares issuable upon the exercise of
the Warrants was declared effective by the Commission. The Company shall use its best efforts to maintain the effectiveness of such registration statement (and any replacement registration statement filed in respect thereof), and a current
prospectus relating thereto, until the expiration of the Warrants in accordance with the provisions of this Agreement. During any period when the Company shall fail to have maintained an effective registration statement covering the DCFC Ordinary
Shares issuable upon exercise of the Warrants, the Registered Holders of the Warrants shall have the right to exercise such Warrants on a “cashless basis,” by exchanging the Warrants (in accordance with Section 3(a)(9) of the
Securities Act (or any successor statute) or another exemption) for that number of DCFC Ordinary Shares equal to the quotient obtained by dividing (x) the product of the number of DCFC Ordinary Shares underlying the Warrants, multiplied by the
difference between the Warrant Price and the “Fair Market Value” (as defined below) by (y) the Fair Market Value. Solely for purposes of this subsection 7.4.1, “Fair Market Value” shall mean the volume weighted average price
of the DCFC Ordinary Shares as reported during the ten (10) trading day period ending on the trading day prior to the date that notice of exercise is received by the Warrant Agent from the holder of such Warrants or its securities broker or
intermediary. The date that notice of cashless exercise is received by the Warrant Agent shall be conclusively determined by the Warrant Agent. In connection with the “cashless exercise” of a Public Warrant, the Company shall, upon
request, provide the Warrant Agent with an opinion of counsel for the Company (which shall be an outside law firm with securities law experience) stating that (i) the exercise of the Warrants on a cashless basis in accordance with this
subsection 7.4.1 is not required to be registered under the 

  
 11 

 
Securities Act and (ii) the DCFC Ordinary Shares issued upon such exercise shall be freely tradable under United States federal securities laws by anyone who is not an affiliate (as such
term is defined in Rule 144 under the Securities Act (or any successor rule)) of the Company and, accordingly, shall not be required to bear a restrictive legend. Except as provided in subsection 7.4.2, for the avoidance of any doubt, unless and
until all of the Warrants have been exercised, the Company shall continue to be obligated to comply with its registration obligations under the first three sentences of this subsection 7.4.1. 

7.4.2    Cashless Exercise at Company’s Option. If the DCFC Ordinary Shares are at the time of any exercise
of a Warrant not listed on a national securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1) of the Securities Act (or any successor statute), the Company may, at its option,
(i) require holders of Public Warrants who exercise Public Warrants to exercise such Public Warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act (or any successor statute) as described in
subsection 7.4.1 and (ii) in the event the Company so elects, the Company shall (x) not be required to file or maintain in effect a registration statement for the registration, under the Securities Act, of the DCFC Ordinary Shares issuable
upon exercise of the Warrants, notwithstanding anything in this Agreement to the contrary, and (y) use its best efforts to register or qualify the DCFC Ordinary Shares issuable upon exercise of the Public Warrant under the blue sky laws of the
state of residence of the exercising Public Warrant holder to the extent an exemption is not available. 

8.    Concerning the Warrant Agent and Other Matters. 

8.1    Payment of Taxes. The Company shall from time to time promptly pay all taxes and charges that may be imposed
upon the Company or the Warrant Agent in respect of the issuance or delivery of DCFC Ordinary Shares upon the exercise of the Warrants, but neither the Company nor the Warrant Agent shall be obligated to pay any transfer taxes in respect of the
Warrants or such DCFC Ordinary Shares, save as expressly stated in this Section 8.1. 
 8.2    Resignation,
Consolidation, or Merger of Warrant Agent. 
 8.2.1    Appointment of Successor Warrant Agent. The Warrant
Agent, or any successor to it hereafter appointed, may resign its duties and be discharged from all further duties and liabilities hereunder after giving sixty (60) days’ notice in writing to the Company. If the office of the Warrant Agent
becomes vacant by resignation or incapacity to act or otherwise, the Company shall appoint in writing a successor Warrant Agent in place of the Warrant Agent. If the Company shall fail to make such appointment within a period of thirty
(30) days after it has been notified in writing of such resignation or incapacity by the Warrant Agent or by the holder of a Warrant (who shall, with such notice, submit his, her or its Warrant for inspection by the Company), then the holder of
any Warrant may apply to the Supreme Court of the State of New York for the County of New York for the appointment of a successor Warrant Agent at the Company’s cost. Any successor Warrant Agent, whether appointed by the Company or by such
court, shall be a corporation or other entity organized and existing under the laws of the United States of America, or any state thereof, in good standing and having its principal office in the United States of America, and authorized under such
laws to exercise corporate trust or stock transfer powers and subject to supervision or examination by federal or state authority. After appointment, any successor Warrant Agent shall be vested with all the authority, powers, rights, immunities,
duties, and obligations of its predecessor Warrant Agent with like effect as if originally named as Warrant Agent hereunder, without any further act or deed; but if for any reason it becomes necessary or appropriate, the predecessor Warrant Agent
shall execute and deliver, at the expense of the Company, an instrument transferring to such successor Warrant Agent all the authority, powers, and rights of such predecessor Warrant Agent hereunder; and upon request of any successor Warrant Agent
the Company shall make, execute, acknowledge, and deliver any and all instruments in writing for more fully and effectually vesting in and confirming to such successor Warrant Agent all such authority, powers, rights, immunities, duties, and
obligations. 
 8.2.2    Notice of Successor Warrant Agent. In the event a successor Warrant Agent shall be
appointed, the Company shall give notice thereof to the predecessor Warrant Agent and the Transfer Agent not later than the effective date of any such appointment. 

  
 12 

 8.2.3    Merger or Consolidation of Warrant Agent. Any entity
into which the Warrant Agent may be merged or with which it may be consolidated or any entity resulting from any merger or consolidation to which the Warrant Agent shall be a party shall be the successor Warrant Agent under this Agreement without
any further act. 
 8.3    Fees and Expenses of Warrant Agent. 

8.3.1    Remuneration. The Company agrees to pay to the Warrant Agent reasonable compensation for all services
rendered by it hereunder in accordance with a fee schedule to be mutually agreed upon and, from time to time, on demand of the Warrant Agent, its reasonable and documented expenses and counsel fees and disbursements and other disbursements incurred
in the preparation, negotiation, execution, administration, delivery and amendment of this Agreement and the exercise and performance of its duties hereunder. 

8.3.2    Further Assurances. The Company agrees to perform, execute, acknowledge, and deliver or cause to be
performed, executed, acknowledged, and delivered all such further and other acts, instruments, and assurances as may reasonably be required by the Warrant Agent for the carrying out or performing of the provisions of this Agreement. 

8.4    Liability of Warrant Agent. 

8.4.1    Reliance on Company Statement. Whenever in the performance of its duties under this Agreement, the
Warrant Agent shall deem it necessary or desirable that any fact or matter be proved or established by the Company prior to taking, suffering or omitting to take any action hereunder, such fact or matter (unless other evidence in respect thereof be
herein specifically prescribed) may be deemed to be conclusively proved and established by a statement signed by the Chief Executive Officer, Chief Financial Officer, Secretary or Chairman of the Board and delivered to the Warrant Agent. The Warrant
Agent may rely upon such statement for any action taken, suffered or omitted to be taken by it pursuant to the provisions of this Agreement. 

8.4.2    Indemnity. The Warrant Agent shall be liable hereunder only for its own gross negligence, willful
misconduct or bad faith (in each case, as determined by a final, non-appealable judgment of a court of competent jurisdiction). The Company agrees to indemnify the Warrant Agent and save it harmless against
any and all liabilities loss, damage, judgment, fine, penalty, claim, demand, settlement, reasonable cost or expense that is paid, incurred or to which it becomes subject, including judgments, costs and reasonable counsel fees, for anything done or
omitted by the Warrant Agent for any action taken, suffered or omitted to be taken by the Warrant Agent in connection with the execution, acceptance, administration, exercise and performance of its duties under this Agreement, including the
reasonable costs and expenses of defending against any claim of liability arising therefrom, directly or indirectly, or of enforcing its rights under this Agreement, except (i) as a result of the Warrant Agent’s gross negligence, willful
misconduct or bad faith (in each case as determined by a final, non-appealable judgment of a court of competent jurisdiction); or (ii) any Tax imposed on or calculated as a result of the net income
received or receivable by the Warrant Agent under applicable law. Notwithstanding anything in this Agreement to the contrary, in no event shall the Warrant Agent be liable for special, punitive, incidental, indirect or consequential loss or damage
of any kind whatsoever, even if the Warrant Agent has been advised of the likelihood of such loss or damage and regardless of the form of the action. Notwithstanding anything to the contrary herein, any liability, other than liability arising out of
or attributable to the Warrant Agent’s gross negligence, willful misconduct or bad faith (in each case as determined by a final, non-appealable judgment of a court of competent jurisdiction) of the
Warrant Agent under this Agreement shall be limited to the amount of fees (but not including any reimbursed costs) paid by the Company to the Warrant Agent during the twelve (12) months immediately preceding the event for which recovery from
the Warrant Agent is being sought. 
 8.4.3    Exclusions. The Warrant Agent shall have no responsibility with
respect to the validity of this Agreement or with respect to the validity or execution of any Warrant (except its countersignature thereof). The Warrant Agent shall not be responsible for any breach by the Company of any covenant or condition
contained in this Agreement or in any Warrant. The Warrant Agent shall not be responsible to make any adjustments required under the provisions of Section 4 hereof or responsible for the manner, method, or amount of any such adjustment or the
ascertaining of the existence of facts that would require any such adjustment; nor shall it by any act hereunder be deemed to make any representation or warranty as to the authorization or reservation of any DCFC Ordinary Shares to be issued
pursuant to this Agreement or any Warrant or as to whether any DCFC Ordinary Shares shall, when issued, be valid and fully paid and non-assessable. 

  
 13 

 8.5    Other Rights of the Warrant Agent. 

8.5.1    Counsel. The Warrant Agent may consult with legal counsel (who may be legal counsel for the Company), and
the opinion or advice of such counsel shall be full and complete authorization and protection to the Warrant Agent as to any action taken or omitted by it in accordance with such opinion or advice. 

8.5.2    Reliance on Attorneys and Agents. The Warrant Agent may execute and exercise any of the rights or powers
hereby vested in it or perform any duty hereunder either itself or by or through its attorney or agents, and the Warrant Agent shall not be answerable or accountable for any act, default, neglect or misconduct of any such attorney or agents or for
any loss to the Company resulting from any such act, default, neglect or misconduct, absent gross negligence, bad faith or willful misconduct (each as determined by a final non-appealable judgment of a court
of competent jurisdiction) in the selection and continued employment thereof. 
 8.5.3    Company Instructions.
The Warrant Agent may rely on and shall be held harmless and protected and shall incur no liability for or in respect of any action taken, suffered or omitted to be taken by it in reliance upon any certificate, statement, instrument, opinion,
notice, letter, facsimile transmission, or other document, or any security delivered to it, and believed by it to be genuine and to have been made or signed by the proper party or parties, or upon any written instructions or statements from the
Company with respect to any matter relating to its acting as Warrant Agent hereunder. 
 8.5.4    No Risk of Own
Funds. The Warrant Agent shall not be obligated to expend or risk its own funds or to take any action that it believes would expose or subject it to expense or liability or to a risk of incurring expense or liability, unless it has been
furnished with assurances of repayment or indemnity satisfactory to it. 
 8.5.5    Opinion of Counsel. The
Company shall provide an opinion of counsel reasonably satisfactory to the Warrant Agent prior to the effective date of this Warrant Agreement which shall state that all Warrants are: (1) registered under the Securities Act of 1933, as amended,
or are exempt from such registration, and all appropriate state securities law filings have been made with respect to the warrants; and (2) validly issued, fully paid and non-assessable. 

8.5.6    Bank Accounts. All funds received by Computershare under this Agreement that are to be distributed or
applied by Computershare in the performance of services hereunder (the “Funds”) shall be held by Computershare as agent for the Company and deposited in one or more bank accounts to be maintained by Computershare in its name
as agent for the Company and shall distribute or apply, as applicable, such Funds in accordance with the terms and conditions herein. Computershare shall have no responsibility or liability for any diminution of the Funds that may result from any
deposit made by Computershare in accordance with this paragraph, including any losses resulting from a default by any bank, financial institution or other third party. Computershare may from time to time receive interest, dividends or other earnings
in connection with such deposits. Computershare shall not be obligated to pay such interest, dividends or earnings to the Company, any holder or any other party. 

8.6    Acceptance of Agency. The Warrant Agent hereby accepts the agency established by this Agreement and agrees
to perform the same upon the express terms and conditions herein set forth and among other things, shall account promptly to the Company with respect to Warrants exercised and concurrently account for, and pay to the Company, all monies received by
the Warrant Agent for the purchase of DCFC Ordinary Shares through the exercise of the Warrants. 

8.7    Survival. The obligations of the Company under this Section 8 shall survive the termination of this
Agreement, the resignation, replacement or removal of the Warrant Agent and the exercise, termination and expiration of the Warrant. 

  
 14 

 8.8    Delivery of Exercise Price. The Warrant Agent shall
forward funds received for warrant exercises in a given month by the 5th Business Day of the following month by wire transfer to an account designated by the Company. 

8.9    Confidentiality. The Warrant Agent and the Company agree that all books, records, information and data
pertaining to the business of the other party, including inter alfa, personal, non-public warrant holder information, which are exchanged or received pursuant to the negotiation or the carrying out of
this Agreement including the fees for services shall remain confidential, and shall not be voluntarily disclosed to any other person, except as may be required by law, including, without limitation, pursuant to (i) subpoenas from state or
federal government authorities (e.g., in divorce and criminal actions) or (ii) securities law disclosure rule or disclosure rules of the Commission or any stock exchange. However, each party hereto may disclose relevant aspects of the other
party’s confidential information to its officers, affiliates, employees and advisors to the extent reasonably necessary to perform its duties and obligations hereunder. 

9.    Miscellaneous Provisions. 

9.1    Successors. All the covenants and provisions of this Agreement by or for the benefit of the Company or the
Warrant Agent shall bind and inure to the benefit of their respective successors and assigns. 
 9.2    Notices.
Any notice, statement or demand authorized by this Agreement to be given or made by the Warrant Agent or by the holder of any Warrant to or on the Company shall be sufficiently given when so delivered if by hand or overnight delivery or if sent by
certified mail or private courier service within five (5) days after deposit of such notice, postage prepaid, addressed (until another address is filed in writing by the Company with the Warrant Agent), as follows: 

Tritium DCFC Limited 
 48 Miller
Street 
 Murarrie, QLD 4172 

Australia 
 Attention: Mark Anning

 Email: manning@tritium.com.au 

With a copy to: 

Latham & Watkins LLP 

330 North Wabash Avenue, Suite 2800 

Chicago, Illinois 60611 

Attention: Christopher Lueking 

Email: Christopher.Lueking@lw.com 

and 
 Corrs Chambers Westgarth

 Level 42, 111 Eagle Street 

Brisbane, QLD 4000 
 Australia
Attention: Alex Feros 
 Email: Alexandra.Feros@corrs.com.au 

Any notice, statement or demand authorized by this Agreement to be given or made by the holder of any Warrant or by the Company to or on the Warrant Agent
shall be in writing and sufficiently given when so delivered if by hand or overnight delivery or if sent by certified mail or private courier service within five (5) days after deposit of such notice, postage prepaid, addressed (until another
address is filed in writing by the Warrant Agent with the Company), as follows: 
 Computershare Inc. 

Computershare Trust Company, N.A. 

150 Royall Street 
 Canton, MA
02021 
 Attn: Client Services 

  
 15 

 9.3    Applicable Law. The validity, interpretation, and
performance of this Agreement and of the Warrants shall be governed in all respects by the laws of the State of New York, without giving effect to conflicts of law principles that would result in the application of the substantive laws of another
jurisdiction. The Company hereby agrees that any action, proceeding or claim against it arising out of or relating in any way to this Agreement, including under the Securities Act, shall be brought and enforced in the courts of the State of New York
or the United States District Court for the Southern District of New York, and irrevocably submits to such jurisdiction, which jurisdiction shall be exclusive; provided, however, that the foregoing shall not apply to suits brought to enforce any
liability or duty created by the Exchange Act or any other claim for which the federal district courts of the United States of America are the sole and exclusive forum. The Company hereby waives any objection to such exclusive jurisdiction and that
such courts represent an inconvenient forum. 
 9.4    Persons Having Rights under this Agreement. Nothing in
this Agreement shall be construed to confer upon, or give to, any person or entity other than the parties hereto and the Registered Holders of the Warrants any right, remedy, or claim under or by reason of this Agreement or of any covenant,
condition, stipulation, promise, or agreement hereof. All covenants, conditions, stipulations, promises, and agreements contained in this Agreement shall be for the sole and exclusive benefit of the parties hereto and their successors and assigns
and of the Registered Holders of the Warrants. 
 9.5    Examination of the Warrant Agreement. A copy of this
Agreement shall be available at all reasonable times at the office of the Warrant Agent in the Borough of Manhattan, City and State of New York, for inspection by the Registered Holder of any Warrant. The Warrant Agent may require any such holder to
submit such holder’s Warrant for inspection by the Warrant Agent. 
 9.6    Counterparts. This Agreement may
be executed in any number of original or facsimile counterparts and each of such counterparts shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument. 

9.7    Effect of Headings. The section headings herein are for convenience only and are not part of this Agreement
and shall not affect the interpretation thereof. 
 9.8    Amendments. This Agreement may be amended by the
parties hereto without the consent of any Registered Holder for the purpose of curing any ambiguity, or curing, correcting or supplementing any defective provision contained herein or adding or changing any other provisions with respect to matters
or questions arising under this Agreement as the parties may deem necessary or desirable and that the parties deem shall not adversely affect the interest of the Registered Holders. All other modifications or amendments, including any amendment to
increase the Warrant Price or shorten the Exercise Period and any amendment to the terms of only the Private Placement Warrants, shall require the vote or written consent of the Registered Holders of 50% of the then outstanding Public Warrants;
provided that if an amendment adversely affects the Private Placement Warrants in a different manner than the Public Warrants or vice versa, then the vote or written consent of the Registered Holders of 65% of the Public Warrants and 65% of
the Private Placement Warrants, voting as separate classes, shall be required. Notwithstanding the foregoing, the Company may lower the Warrant Price or extend the duration of the Exercise Period pursuant to Sections 3.1 and 3.2, respectively,
without the consent of the Registered Holders. No amendment to this Warrant Agent Agreement shall be effective unless duly executed by the Warrant Agent. As a condition precedent to the execution by the Warrant Agent of this Agreement, the Company
shall deliver a certificate from an Authorized Signatory which states that the proposed amendment is in compliance with the terms of this Section 9.8. 

9.9    Severability. This Agreement shall be deemed severable, and the invalidity or unenforceability of any term
or provision hereof shall not affect the validity or enforceability of this Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid or unenforceable term or provision, the parties hereto intend that there shall
be added as a part of this Agreement a provision as similar in terms to such 

  
 16 

 
invalid or unenforceable provision as may be possible and be valid and enforceable; provided, however, that if any excluded provision shall materially affect the rights, immunities, liabilities,
duties or obligations of the Warrant Agent, the Warrant Agent shall be entitled to resign immediately upon written notice to the Company. 

9.10    Force Majeure. Notwithstanding anything to the contrary contained herein, the Warrant Agent shall not be
liable for any delays or failures in performance resulting from acts beyond its reasonable control including, without limitation, acts of God, terrorist acts, epidemics, pandemics, shortage of supply, breakdowns or malfunctions, interruptions or
malfunctions of any utilities, communications, or computer facilities, or loss of data due to power failures or mechanical difficulties with information storage or retrieval systems, labor difficulties, war or civil unrest. 

Exhibit A — Form of Warrant Certificate 

  
 17 

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of
the date first above written. 
  

			
	TRITIUM DCFC LIMITED
		
	By:	 	 /s/ Jane Hunter

		 	Name: Jane Hunter
		 	Title: Chief Executive Officer

  

			
	COMPUTERSHARE INC.
	COMPUTERSHARE TRUST COMPANY, N.A., as Warrant Agent
		
	By:	 	 /s/ Collin Ekeogu

		 	Name: Collin Ekeogu
		 	Title: Mgr Corporate Actions

  
 [Signature Page to
Warrant Agreement] 

 EXHIBIT A 

[Form of Warrant Certificate] 

[FACE] 
 Number 

Warrants 
  

 
 THIS WARRANT
SHALL BE VOID IF NOT EXERCISED PRIOR TO 
 THE EXPIRATION OF THE EXERCISE PERIOD PROVIDED FOR 

IN THE WARRANT AGREEMENT DESCRIBED BELOW 

TRITIUM DCFC LIMTED  

an Australian public company limited by shares 

CUSIP Q9225T 116 
 Warrant
Certificate 
 This Warrant Certificate certifies that         , or registered
assigns, is the registered holder of warrant(s) evidenced hereby (the “Warrants” and each, a “Warrant”) to purchase ordinary shares (“Ordinary Shares”) of Tritium DCFC Limited,
an Australian public company limited by shares (the “Company”). Each Warrant entitles the holder, upon exercise during the period set forth in the Warrant Agreement referred to on the reverse hereof, to receive from the
Company that number of fully paid and non-assessable Ordinary Shares as set forth below, at the exercise price (the “Exercise Price”) as determined pursuant to the Warrant Agreement,
payable in lawful money (or through “cashless exercise” as provided for in the Warrant Agreement) of the United States of America upon surrender of this Warrant Certificate and payment of the Exercise Price at the office or
agency of the Warrant Agent referred to below, subject to the conditions set forth herein and in the Warrant Agreement. Defined terms used in this Warrant Certificate but not defined herein shall have the meanings given to them in the Warrant
Agreement. 
 Each Warrant is initially exercisable for one fully paid and non-assessable Ordinary
Share. The number of Ordinary Shares issuable upon exercise of the Warrants is subject to adjustment upon the occurrence of certain events set forth in the Warrant Agreement. 

The initial Exercise Price per Ordinary Share for any Warrant is equal to $11.50 per share. The Exercise Price is subject to adjustment upon
the occurrence of certain events set forth in the Warrant Agreement. 
 Subject to the conditions set forth in the Warrant Agreement, the
Warrants may be exercised only during the Exercise Period and to the extent not exercised by the end of such Exercise Period, such Warrants shall become void. 

Reference is hereby made to the further provisions of this Warrant Certificate set forth on the reverse hereof and such further provisions
shall for all purposes have the same effect as though fully set forth at this place. 
 This Warrant Certificate shall not be valid unless
countersigned by the Warrant Agent, as such term is used in the Warrant Agreement. 
 This Warrant Certificate shall be governed by and
construed in accordance with the internal laws of the State of New York, without regard to conflicts of laws principles thereof. 
  

  
 A-1 

 
			
	 TRITIUM DCFC LIMITED

		
	 By:
	 	  

		 	 Name:

		 	 Title:

	
	 COMPUTERSHARE INC.

	 COMPUTERSHARE TRUST COMPANY, N.A., as

	 Warrant Agent

		
	 By:
	 	  

		 	 Name:

		 	 Title:

  

  
 A-2 

 [Form of Warrant Certificate] 

[Reverse] 
 The Warrants
evidenced by this Warrant Certificate are part of a duly authorized issue of Warrants entitling the holder on exercise to receive Ordinary Shares and are issued or to be issued pursuant to the Amended and Restated Warrant Agreement dated as of
January 13, 2022 (the “Warrant Agreement”), duly executed and delivered by the Company to Computershare Inc., a Delaware corporation, and its wholly owned subsidiary, Computershare Trust Company, N.A., a
federally chartered trust company, as warrant agent (the “Warrant Agent”), which Warrant Agreement is hereby incorporated by reference in and made a part of this instrument and is hereby referred to for a
description of the rights, limitation of rights, obligations, duties and immunities thereunder of the Warrant Agent, the Company and the holders (the words “holders” or “holder”
meaning the Registered Holders or Registered Holder) of the Warrants. A copy of the Warrant Agreement may be obtained by the holder hereof upon written request to the Company. Defined terms used in this Warrant Certificate but not defined
herein shall have the meanings given to them in the Warrant Agreement. 
 Warrants may be exercised at any time during the Exercise Period
set forth in the Warrant Agreement. The holder of Warrants evidenced by this Warrant Certificate may exercise them by surrendering this Warrant Certificate, with the form of election to purchase set forth hereon properly completed and executed,
together with payment of the Exercise Price as specified in the Warrant Agreement (or through “cashless exercise” as provided for in the Warrant Agreement) at the principal corporate trust office of the Warrant Agent. In the
event that upon any exercise of Warrants evidenced hereby the number of Warrants exercised shall be less than the total number of Warrants evidenced hereby, there shall be issued to the holder hereof or his, her or its assignee, a new Warrant
Certificate evidencing the number of Warrants not exercised. 
 Notwithstanding anything else in this Warrant Certificate or the Warrant
Agreement, no Warrant may be exercised unless at the time of exercise (i) a registration statement covering the Ordinary Shares to be issued upon exercise is effective under the Securities Act and (ii) a prospectus thereunder relating to
the Ordinary Shares are current, except through “cashless exercise” as provided for in the Warrant Agreement. 
 The
Warrant Agreement provides that upon the occurrence of certain events the number of Ordinary Shares issuable upon exercise of the Warrants set forth on the face hereof may, subject to certain conditions, be adjusted. If, upon exercise of a Warrant,
the holder thereof would be entitled to receive a fractional interest in an Ordinary Share, the Company shall, upon exercise, round down to the nearest whole number of Ordinary Shares to be issued to the holder of the Warrant. 

Warrant Certificates, when surrendered at the principal corporate trust office of the Warrant Agent by the Registered Holder thereof in person
or by legal representative or attorney duly authorized in writing, may be exchanged, in the manner and subject to the limitations provided in the Warrant Agreement, but without payment of any service charge, for another Warrant Certificate or
Warrant Certificates of like tenor evidencing in the aggregate a like number of Warrants. 
 Upon due presentation for registration of
transfer of this Warrant Certificate at the office of the Warrant Agent a new Warrant Certificate or Warrant Certificates of like tenor and evidencing in the aggregate a like number of Warrants shall be issued to the transferee(s) in exchange for
this Warrant Certificate, subject to the limitations provided in the Warrant Agreement, without charge except for any tax or other governmental charge imposed in connection therewith. 

The Company and the Warrant Agent may deem and treat the Registered Holder(s) hereof as the absolute owner(s) of this Warrant Certificate
(notwithstanding any notation of ownership or other writing hereon made by anyone), for the purpose of any exercise hereof, of any distribution to the holder(s) hereof, and for all other purposes, and neither the Company nor the Warrant Agent shall
be affected by any notice to the contrary. Neither the Warrants nor this Warrant Certificate entitles any holder hereof to any rights of a stockholder of the Company. 
  

  
 A-3 

 Election to Purchase 

(To Be Executed Upon Exercise of Warrant) 

The undersigned hereby irrevocably elects to exercise the right, represented by this Warrant Certificate, to
receive                Ordinary Shares and herewith tenders payment for such Ordinary Shares to the order of Tritium DCFC Limited (the “Company”) in the
amount of $                in accordance with the terms hereof. The undersigned requests that a certificate for such Ordinary Shares be registered in the name
of                , whose address is                and that such Ordinary Shares be
delivered to                whose address is                . If said number of Ordinary
Shares is less than all of the Ordinary Shares purchasable hereunder, the undersigned requests that a new Warrant Certificate representing the remaining balance of such Ordinary Shares be registered in the name
of                , whose address is and that such Warrant Certificate be delivered
to                , whose address is                . 

In the event that the Warrant has been called for redemption by the Company pursuant to Section 6.2 of the Warrant Agreement and a holder
thereof elects to exercise its Warrant pursuant to a Make-Whole Exercise, the number of Ordinary Shares that this Warrant is exercisable for shall be determined in accordance with subsection 3.3.1(c) or Section 6.2 of the Warrant Agreement, as
applicable. 
 In the event that the Warrant is a Private Placement Warrant that is to be exercised on a “cashless” basis pursuant
to subsection 3.3.1(c) of the Warrant Agreement, the number of Ordinary Shares that this Warrant is exercisable for shall be determined in accordance with subsection 3.3.1(c) of the Warrant Agreement. 

In the event that the Warrant is to be exercised on a “cashless” basis pursuant to Section 7.4 of the Warrant
Agreement, the number of Ordinary Shares that this Warrant is exercisable for shall be determined in accordance with Section 7.4 of the Warrant Agreement. 

In the event that the Warrant may be exercised, to the extent allowed by the Warrant Agreement, through cashless exercise (i) the number
of Ordinary Shares that this Warrant is exercisable for would be determined in accordance with the relevant section of the Warrant Agreement which allows for such cashless exercise; (ii) the holder hereof hereby undertakes to pay on demand the
relevant aggregate nominal value for the Ordinary Shares to be issued; and (iii) the holder hereof shall complete the following: The undersigned hereby irrevocably elects to exercise the right, represented by this Warrant Certificate, through
the cashless exercise provisions of the Warrant Agreement, to receive Ordinary Shares. If said number of shares is less than all of the Ordinary Shares purchasable hereunder (after giving effect to the cashless exercise), the undersigned requests
that a new Warrant Certificate representing the remaining balance of such Ordinary Shares be registered in the name of                , whose address
is                and that such Warrant Certificate be delivered to                ,
whose address is                . 
 [Signature Page Follows]

  
 A-4 

							
	Date:             , 20	 		 		 	  

		 		 		 	(Signature)
				
		 		 		 	  

		 		 		 	  

		 		 		 	  

		 		 		 	(Address)
				
		 		 		 	  

		 		 		 	(Tax Identification Number)

 Signature Guaranteed: 
  

 
 THE SIGNATURE(S) SHOULD BE GUARANTEED BY
AN ELIGIBLE GUARANTOR INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM, PURSUANT TO S.E.C. RULE 17Ad-15 (OR
ANY SUCCESSOR RULE)) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. 
  

  
 A-5EX-10.1

 Exhibit 10.1 

Execution Version 

AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT 

THIS AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of January 13, 2022, is made
and entered into by and among Tritium DCFC Limited (ACN 650 026 314), an Australian public company (the “Company”), Decarbonization Plus Acquisition Corporation II, a Delaware corporation (the “SPAC”),
Decarbonization Plus Acquisition Sponsor II LLC, a Delaware limited liability company (the “Sponsor”), and the undersigned parties listed under Holder on the signature pages hereto (each such party, together with the Sponsor
and any person or entity who hereafter becomes a party to this Agreement pursuant to Section 5.2 of this Agreement, a “Holder” and collectively, the “Holders”). 

RECITALS 
 WHEREAS,
on February 3, 2021, the SPAC, the Sponsor and certain other security holders named therein (the “SPAC Holders”) entered into that certain Registration Rights Agreement (the “SPAC Registration Rights
Agreement”), pursuant to which the SPAC granted the Sponsor and such other SPAC Holders certain registration rights with respect to certain securities of the SPAC; 

WHEREAS, on May 25, 2021, the SPAC, the Company, Hulk Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of the
Company (“Merger Sub”), and Tritium Holdings Pty Ltd (ACN 145 324 910), an Australian propriety company (“Tritium”), entered into that certain Business Combination Agreement (as amended, the
“BCA”), pursuant to which, among other things, (i) Merger Sub will merge with and into the SPAC on or about the date hereof, with the SPAC surviving the merger as a wholly owned subsidiary of the Company and the
stockholders and warrant holders of the SPAC receiving ordinary shares of the Company (“Ordinary Shares”) and warrants to purchase Ordinary Shares, respectively, and (ii) the equity holders of Tritium will enter into a
Share Transfer Agreement pursuant to which they will transfer their Tritium securities to the Company in exchange for Ordinary Shares (collectively, the “Business Combination”); 

WHEREAS, after the closing of the Business Combination (the “Closing”), the Holders will own Ordinary Shares,
and the Sponsor, James AC McDermott, Jeffrey Tepper, Dr. Jennifer Aaker, Jane Kearns and Michael Warren will own warrants to purchase 7,366,667 Ordinary Shares (the “Private Placement Warrants”); and 

WHEREAS, in connection with the Closing, the SPAC and the SPAC Holders desire to amend and restate the SPAC Registration Rights
Agreement in its entirety as set forth herein, and the Company and the other Holders desire to enter into this Agreement, pursuant to which the Company shall grant the Holders certain registration rights with respect to certain securities of the
Company, as set forth in this Agreement. 
 NOW, THEREFORE, in consideration of the representations, covenants and agreements
contained herein, and certain other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby agree as follows: 

ARTICLE I 
 DEFINITIONS

 1.1    Definitions. The terms defined in this Article I shall, for all purposes of this Agreement,
have the respective meanings set forth below: 
 “Agreement” shall have the meaning given in the Preamble. 

“BCA” shall have the meaning given in the Recitals. 

“Block Trade” shall have the meaning given to it in subsection 2.3.1 of this Agreement. 

“Board” shall mean the board of directors of the Company. 

“Business Combination” shall have the meaning given in the Recitals. 

  
 1 

 “Commission” shall mean the Securities and Exchange Commission. 

“Company” shall have the meaning given in the Preamble. 

“Demanding Holder” shall mean any Holder or group of Holders that together elects to dispose of Registrable Securities
having an aggregate value of at least US$25 million, at the time of the Underwritten Demand, under a Registration Statement pursuant to an Underwritten Offering. 

“Effectiveness Period” shall have the meaning given in subsection 3.1.1 of this Agreement. 

“Exchange Act” shall mean the Securities Exchange Act of 1934, as it may be amended from time to time. 

“Financial Counterparty” shall have the meaning given in subsection 2.3.1 of this Agreement. 

“Holder Indemnified Persons” shall have the meaning given in subsection 4.1.1 of this Agreement. 

“Holders” shall have the meaning given in the Preamble. 

“Maximum Number of Securities” shall have the meaning given in subsection 2.1.3 of this Agreement. 

“Merger Sub” shall have the meaning given in the Recitals. 

“Misstatement” shall mean an untrue statement of a material fact or an omission to state a material fact required to
be stated in a Registration Statement or Prospectus, or necessary to make the statements in a Registration Statement or Prospectus (in the light of the circumstances under which they were made) not misleading. 

“Ordinary Shares” shall have the meaning given in the Recitals. 

“Other Coordinated Offering” shall have the meaning given to it in subsection 2.3.1 of this Agreement. 

“Piggyback Registration” shall have the meaning given in subsection 2.2.1 of this Agreement. 

“Private Placement Warrants” shall have the meaning given in the Recitals. 

“Pro Rata” shall have the meaning given in subsection 2.1.3 of this Agreement. 

“Prospectus” shall mean the prospectus included in any Registration Statement, as supplemented by any and all
prospectus supplements and as amended by any and all post-effective amendments and including all material incorporated by reference in such prospectus. 

“Registrable Security” shall mean (a) the Private Placement Warrants (including any Ordinary Shares issued or
issuable upon the exercise of any such Private Placement Warrants) held by a Holder immediately following the Closing, (b) any outstanding Ordinary Shares held by a Holder immediately following the Closing (including any Ordinary Shares issued
or issuable upon exercise of any other outstanding equity securities of the Company (other than equity securities issued pursuant to an employee stock option or other benefit plan) held by a Holder immediately following the Closing), (c) any equity
securities (including the Ordinary Shares issued or issuable upon the exercise of any such equity security) of the Company issuable immediately following the Closing upon conversion of any working capital loans in an amount up to US$1,500,000 in the
aggregate made to the SPAC by a Holder and (d) any other equity security of the Company issued or issuable with respect to any such Ordinary Shares held by a Holder immediately following the Closing by way of a share sub-division or share dividend or in connection with a combination of shares, recapitalization, merger, consolidation or reorganization; provided, however, that, as to any particular Registrable
Securities, such securities shall cease to be Registrable Securities when: (A) a Registration Statement with respect to the sale of such securities shall have become effective under the Securities Act and such securities shall have been sold,
transferred, disposed of or exchanged in accordance with such Registration Statement; (B) such securities shall have been otherwise transferred, new certificates for such securities not bearing a legend restricting further transfer shall have
been delivered by the Company and subsequent public distribution of such 

  
 2 

 
securities shall not require registration under the Securities Act; (C) such securities shall have ceased to be outstanding; or (D) such securities may be sold without registration
pursuant to Rule 144 promulgated under the Securities Act (or any successor rule promulgated thereafter by the Commission) (but with no volume or other restrictions or limitations). 

“Registration” shall mean a registration effected by preparing and filing a registration statement or similar document
in compliance with the requirements of the Securities Act, and the applicable rules and regulations promulgated thereunder, and any such registration statement having been declared effective by, or become effective pursuant to rules promulgated by,
the Commission. 
 “Registration Expenses” shall mean the out-of-pocket expenses of a Registration, including, without limitation, the following: 

(A)    all registration and filing fees (including fees with respect to filings required to be made with the Financial
Industry Regulatory Authority and any securities exchange on which the Ordinary Shares is then listed); 
 (B)    fees
and expenses of compliance with securities or blue sky laws (including reasonable fees and disbursements of counsel for the Underwriters in connection with blue sky qualifications of Registrable Securities); 

(C)    printing, messenger, telephone and delivery expenses; 

(D)    reasonable fees and disbursements of counsel for the Company; 

(E)    reasonable fees and disbursements of all independent registered public accountants of the Company incurred
specifically in connection with such Registration; and 
 (F)    reasonable fees and expenses of one (1) legal
counsel selected by the majority-in-interest of Registrable Securities held by the Demanding Holders initiating an Underwritten Demand to be registered for offer and
sale in the applicable Underwritten Offering, not to exceed US$50,000. 
 “Registration Statement” shall mean any
registration statement under the Securities Act that covers the Registrable Securities pursuant to the provisions of this Agreement, including the Prospectus included in such registration statement, amendments (including post-effective amendments)
and supplements to such registration statement, and all exhibits to and all material incorporated by reference in such registration statement. 

“Requesting Holder” shall have the meaning given in subsection 2.1.2 of this Agreement. 

“Securities Act” shall mean the Securities Act of 1933, as amended from time to time. 

“Shelf Registration” shall have the meaning given in subsection 2.1.1. 

“SPAC” shall have the meaning given in the Preamble. 

“SPAC Holders” shall have the meaning given in the Recitals. 

“SPAC Registration Rights Agreement” shall have the meaning given in the Recitals. 

“Sponsor” shall have the meaning given in the Preamble. 

“Suspension Event” shall have the meaning given in Section 3.4 of this Agreement. 

“Tritium” shall have the meaning given in the Recitals. 

“Underwriter” shall mean a securities dealer who purchases any Registrable Securities as principal in an Underwritten
Offering and not as part of such dealer’s market-making activities. 

  
 3 

 “Underwritten Demand” shall have the meaning given in subsection
2.1.2 of this Agreement. 
 “Underwritten Offering” shall mean a Registration in which securities of the Company
are sold to an Underwriter in a firm commitment underwriting for distribution to the public. 
 ARTICLE II 

REGISTRATIONS 
  

	 	2.1	 Registration. 

2.1.1    Shelf Registration. (a) The Company agrees that, within thirty (30) calendar days after the
consummation of the Business Combination, the Company will file with the Commission (at the Company’s sole cost and expense) a Registration Statement registering the resale of all Registrable Securities (a “Shelf
Registration”). 
 (b)    The Company shall use its commercially reasonable efforts to cause such
Registration Statement to become effective by the Commission as soon as reasonably practicable after the initial filing of the Registration Statement. Subject to the limitations contained in this Agreement, the Company shall effect any Shelf
Registration on such appropriate registration form of the Commission (a) as shall be selected by the Company and (b) as shall permit the resale or other disposition of the Registrable Securities by the Holders. If at any time a
Registration Statement filed with the Commission pursuant to Section 2.1.1 is effective and a Holder provides written notice to the Company that it intends to effect an offering of all or part of the Registrable Securities included on
such Registration Statement, the Company will use its commercially reasonable efforts to amend or supplement such Registration Statement as may be necessary in order to enable such offering to take place in accordance with the terms of this
Agreement. 
 2.1.2    Underwritten Offering. Subject to the provisions of subsection 2.1.3 and
Section 2.3 of this Agreement, any Demanding Holder may make a written demand to the Company for an Underwritten Offering pursuant to a Registration Statement filed with the Commission in accordance with Section 2.1.1 of this
Agreement (an “Underwritten Demand”). The Company shall, within ten (10) days of the Company’s receipt of the Underwritten Demand, notify, in writing, all other Holders of such demand, and each Holder who thereafter
wishes to include all or a portion of such Holder’s Registrable Securities in such Underwritten Offering pursuant to an Underwritten Demand (each such Holder that includes all or a portion of such Holder’s Registrable Securities in such
Underwritten Offering, a “Requesting Holder”) shall so notify the Company, in writing, within five (5) days after the receipt by the Holder of the notice from the Company. Upon receipt by the Company of any such written
notification from a Requesting Holder(s), such Requesting Holder(s) shall be entitled to have their Registrable Securities included in the Underwritten Offering pursuant to an Underwritten Demand. All such Holders proposing to distribute their
Registrable Securities through an Underwritten Offering under this subsection 2.1.2 shall enter into an underwriting agreement in customary form with the Underwriter(s) selected for such Underwritten Offering by the Company in consultation
with the Demanding Holders initiating the Underwritten Offering. Notwithstanding the foregoing, the Company is not obligated to effect (i) more than an aggregate of two (2) Underwritten Offerings pursuant to this subsection 2.1.2 in
any twelve (12)-month period, (ii) more than an aggregate of four (4) Underwritten Offerings pursuant to this subsection 2.1.2 in total, (iii) an Underwritten Offering pursuant to this subsection 2.1.2 within ninety
(90) days after the closing of an Underwritten Offering or (iv) an Underwritten Offering unless the reasonably expected the aggregate gross proceeds from the offering of the Registrable Securities to be registered in connection with such
Underwritten Offering will be at least US$75,000,000 (the “Minimum Amount”). 

2.1.3    Reduction of Underwritten Offering. If the managing Underwriter or Underwriters in an Underwritten
Offering pursuant to an Underwritten Demand, in good faith, advises or advise the Company, the Demanding Holders, the Requesting Holders and other persons or entities holding Ordinary Shares or other equity securities of the Company that the Company
is obligated to include pursuant to separate written contractual arrangements with such persons or entities (if any) in writing that the dollar amount or number of Registrable Securities or other equity securities of the Company requested to be
included in such Underwritten Offering exceeds the maximum dollar amount or maximum number of equity securities of the Company that can be sold in the Underwritten Offering without adversely affecting the proposed offering price, the timing, the
distribution method or the probability of success of such offering (such maximum dollar amount or maximum number of such securities, as applicable, the “Maximum Number of Securities”), then the Company shall include in such
Underwritten Offering, as follows: (i) first, the Registrable Securities of the Demanding Holders and the Requesting Holders (if any) (pro rata 

  
 4 

 
based on the respective number of Registrable Securities that each Demanding Holder and Requesting Holder (if any) has requested be included in such Underwritten Offering and the aggregate number
of Registrable Securities that the Demanding Holders and Requesting Holders have requested be included in such Underwritten Offering (such proportion is referred to herein as “Pro Rata”)) that can be sold without exceeding
the Maximum Number of Securities; (ii) second, to the extent that the Maximum Number of Securities has not been reached under the foregoing clause (i), Ordinary Shares or other equity securities of the Company that the Company desires to
sell and that can be sold without exceeding the Maximum Number of Securities; and (iii) third, to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (i) and (ii), Ordinary Shares
or other equity securities of the Company held by other persons or entities that the Company is obligated to include pursuant to separate written contractual arrangements with such persons or entities and that can be sold without exceeding the
Maximum Number of Securities. 
 2.1.4    Registration Withdrawal. Prior to the filing of the applicable
“red herring” prospectus or prospectus supplement used for marketing such Underwritten Offering, a majority-in-interest of the Demanding Holders initiating an
Underwritten Offering pursuant to subsection 2.1.2 of this Agreement shall have the right to withdraw from such Underwritten Offering for any or no reason whatsoever upon written notification to the Company of their intention to withdraw from
such Underwritten Offering prior to the launch of such Underwritten Offering; provided, however, that upon the withdrawal of an amount of Registrable Securities that results in the remaining amount of Registrable Securities included by
the Demanding Holders and participating Holders in such Underwritten Offering being less than the Minimum Amount, the Company may cease all efforts to complete the Underwritten Offering and, for the avoidance of doubt, if such efforts are ceased,
such Underwritten Offering shall not be counted as an Underwritten Offering for the purpose of the final sentence of subsection 2.1.2. Notwithstanding anything to the contrary in this Agreement, the Company shall be responsible for the
Registration Expenses incurred in connection with an Underwritten Demand prior to its withdrawal under this subsection 2.1.4. 
  

	 	2.2	 Piggyback Registration. 

2.2.1    Piggyback Rights. If the Company proposes to (i) file a Registration Statement under the Securities
Act with respect to the Registration of equity securities of the Company, or securities or other obligations exercisable or exchangeable for, or convertible into equity securities of the Company, for its own account or for the account of
shareholders of the Company, other than a Registration Statement (A) filed in connection with any employee stock option or other benefit plan, (B) pursuant to a Registration Statement on Form S-4 (or
similar form that relates to a transaction subject to Rule 145 under the Securities Act or any successor rule thereto) (C) for an exchange offer or offering of securities solely to the Company’s existing shareholders, (D) for an
offering of debt that is convertible into equity securities of the Company or (E) for a dividend reinvestment plan, or (ii) consummate an Underwritten Offering for its own account or for the account of shareholders of the Company (other
than pursuant to the terms of this Agreement), then the Company shall give written notice of such proposed action to all of the Holders of Registrable Securities as soon as practicable (but in the case of filing a Registration Statement, not less
than ten (10) days before the anticipated filing date of such Registration Statement), which notice shall (x) describe the amount and type of securities to be included, the intended method(s) of distribution and the name of the proposed
managing Underwriter or Underwriters, if any, and (y) offer to all of the Holders of Registrable Securities the opportunity to register the sale of such number of Registrable Securities as such Holders may request in writing within
(a) five (5) days in the case of filing a Registration Statement and (b) two (2) days in the case of an Underwritten Offering (unless such offering is an overnight or bought Underwritten Offering, then one (1) day), in each case after
receipt of such written notice (such Registration, a “Piggyback Registration”). The Company shall, in good faith, cause such Registrable Securities to be included in such Piggyback Registration and shall use its commercially
reasonable efforts to cause the managing Underwriter or Underwriters of a proposed Underwritten Offering to permit the Registrable Securities requested by the Holders pursuant to this subsection 2.2.1 to be included in a Piggyback
Registration on the same terms and conditions as any similar securities of the Company included in such Piggyback Registration and to permit the sale or other disposition of such Registrable Securities in accordance with the intended method(s) of
distribution thereof. If no written request for inclusion from a Holder is received within the specified time, each such Holder shall have no further right to participate in such Piggyback Registration. All such Holders proposing to include
Registrable Securities in an Underwritten Offering under this subsection 2.2.1 shall enter into an underwriting agreement in customary form with the Underwriter(s) selected for such Underwritten Offering by the Company. 

  
 5 

 2.2.2    Reduction of Piggyback Registration. If the managing
Underwriter or Underwriters in an Underwritten Offering that is to be a Piggyback Registration, in good faith, advises the Company and the Holders of Registrable Securities participating in the Piggyback Registration in writing that the dollar
amount or number of shares of the equity securities of the Company that the Company desires to sell, taken together with (i) the shares of equity securities of the Company, if any, as to which Registration or Underwritten Offering has been
demanded pursuant to separate written contractual arrangements with persons or entities other than the Holders of Registrable Securities hereunder, (ii) the Registrable Securities as to which Registration or Underwritten Offering has been
requested pursuant to Section 2.2 of this Agreement and (iii) the shares of equity securities of the Company, if any, as to which Registration or Underwritten Offering has been requested pursuant to separate written contractual
piggyback registration rights of other shareholders of the Company, exceeds the Maximum Number of Securities, then: 

(a)    If the Registration or Underwritten Offering is undertaken for the Company’s account, the Company shall
include in any such Registration or Underwritten Offering (A) first, the Ordinary Shares or other equity securities of the Company that the Company desires to sell, which can be sold without exceeding the Maximum Number of Securities;
(B) second, to the extent that the Maximum Number of Securities has not been reached under the foregoing clause (A), the Registrable Securities of Holders exercising their rights to register their Registrable Securities pursuant to
subsection 2.1.1 of this Agreement, Pro Rata, which can be sold without exceeding the Maximum Number of Securities; and (C) third, to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses
(A) and (B), Ordinary Shares or other equity securities of the Company, if any, as to which Registration or Underwritten Offering has been requested pursuant to written contractual piggyback registration rights of other shareholders
of the Company, which can be sold without exceeding the Maximum Number of Securities; or 
 (b)    If the Registration
or Underwritten Offering is pursuant to a request by persons or entities other than the Holders of Registrable Securities, then the Company shall include in any such Registration or Underwritten Offering (A) first, Ordinary Shares or other
equity securities of the Company, if any, of such requesting persons or entities, other than the Holders of Registrable Securities, which can be sold without exceeding the Maximum Number of Securities; (B) second, to the extent that the Maximum
Number of Securities has not been reached under the foregoing clause (A), the Registrable Securities of Holders exercising their rights to register their Registrable Securities pursuant to subsection 2.1.1 of this Agreement, Pro Rata, which
can be sold without exceeding the Maximum Number of Securities; (C) third, to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (A) and (B), Ordinary Shares or other equity
securities of the Company that the Company desires to sell, which can be sold without exceeding the Maximum Number of Securities; and (D) fourth, to the extent that the Maximum Number of Securities has not been reached under the foregoing
clauses (A), (B) and (C), Ordinary Shares or other equity securities of the Company for the account of other persons or entities that the Company is obligated to register pursuant to separate written contractual arrangements with such
persons or entities, which can be sold without exceeding the Maximum Number of Securities. 
 2.2.3    Piggyback
Registration Withdrawal. Any Holder of Registrable Securities shall have the right to withdraw from a Piggyback Registration for any or no reason whatsoever upon written notification to the Company and the Underwriter or Underwriters (if any) of
his, her or its intention to withdraw from such Piggyback Registration prior to, as applicable, the effectiveness of the Registration Statement filed with the Commission with respect to such Piggyback Registration or the launch of the Underwritten
Offering with respect to such Piggyback Registration. The Company (whether on its own good faith determination or as the result of a request for withdrawal by persons or entities pursuant to separate written contractual obligations) may withdraw a
Registration Statement filed with the Commission in connection with a Piggyback Registration at any time prior to the effectiveness of such Registration Statement or abandon an Underwritten Offering in connection with a Piggyback Registration at any
time prior to the launch of such Underwritten Offering. Notwithstanding anything to the contrary in this Agreement, the Company shall be responsible for the Registration Expenses incurred in connection with the Piggyback Registration prior to its
withdrawal under this subsection 2.2.3. 
 2.2.4    Unlimited Piggyback Registration Rights. For purposes of
clarity, any Registration or Underwritten Offering effected pursuant to Section 2.2 of this Agreement shall not be counted as an Underwritten Offering pursuant to an Underwritten Demand effected under Section 2.1 of this Agreement. 

 

	 	2.3	 Block Trades Other Coordinated Offerings. 

2.3.1    Notwithstanding any other provision of this Article II, but subject to Section 2.4 and Section 3.4, at
any time and from time to time when an effective Registration Statement is on file with the Commission, 

  
 6 

 
if a Demanding Holder wishes to engage in (a) an underwritten registered offering not involving a “roadshow,” an offer commonly known as a “block trade” (a
“Block Trade”) or (b) an “at the market” or similar registered offering through a broker, sales agent or distribution agent, whether as agent or principal, (an “Other Coordinated
Offering”), in each case, with a total offering price reasonably expected to exceed, in the aggregate, either (x) $25 million or (y) all remaining Registrable Securities held by the Demanding Holder, then if such Demanding
Holder requires any assistance from the Company pursuant to this Section 2.3, such Holder shall notify the Company of the Block Trade or Other Coordinated Offering at least five (5) business days prior to the day such offering is to
commence and, as promptly as reasonably practicable, the Company shall use its commercially reasonable efforts to facilitate such Block Trade or Other Coordinated Offering; provided that the Demanding Holders representing a majority of the
Registrable Securities wishing to engage in the Block Trade or Other Coordinated Offering shall use commercially reasonable efforts to work with the Company and any Underwriters or brokers, sales agents or placement agents (each, a
“Financial Counterparty”) prior to making such request in order to facilitate preparation of the registration statement, prospectus and other offering documentation related to the Block Trade or Other Coordinated Offering.

 2.3.2    Prior to the filing of the applicable “red herring” prospectus or prospectus supplement used in
connection with a Block Trade or Other Coordinated Offering, a majority-in interest of the Demanding Holders initiating such Block Trade or Other Coordinated Offering shall have the right to submit a written
notice of withdrawal to the Company, the Underwriter or Underwriters (if any) and Financial Counterparty (if any) of their intention to withdraw from such Block Trade or Other Coordinated Offering. Notwithstanding anything to the contrary in this
Agreement, the Company shall be responsible for the Registration Expenses incurred in connection with a Block Trade or Other Coordinated Offering prior to its withdrawal under this subsection 2.3.2. 

2.3.3    Notwithstanding anything to the contrary in this Agreement, Section 2.2 shall not apply to a Block
Trade or Other Coordinated Offering initiated by a Demanding Holder pursuant to Section 2.3 of this Agreement. 

2.3.4    The Demanding Holder in a Block Trade or Other Coordinated Offering shall have the right to select the
Underwriters and Financial Counterparty (if any) for such Block Trade or Other Coordinated Offering (in each case, which shall consist of one or more reputable nationally recognized investment banks). 

2.3.5    A Holder in the aggregate may demand no more than two (2) Block Trades or Other Coordinated Offerings
pursuant to this Section 2.3 in any twelve (12) month period. For the avoidance of doubt, any Block Trade or Other Coordinated Offering effected pursuant to this Section 2.3 shall not be counted as a demand for an
Underwritten Offering pursuant to subsection 2.1.2 hereof. 
 2.4    Restrictions on Registration Rights.
If (A) the Holders have requested an Underwritten Offering pursuant to an Underwritten Demand and the Company and the Holders are unable to obtain the commitment of underwriters to firmly underwrite the offer; (B) the filing, initial
effectiveness, or continued use of a Registration Statement in respect of such Underwritten Offering at any time would require the inclusion in such Registration Statement of financial statements that are unavailable to the Company for reasons
beyond the Company’s control; or (C) the Holders have requested an Underwritten Offering pursuant to an Underwritten Demand and in the good faith judgment of a majority of the Board that such Underwritten Offering would be seriously
detrimental to the Company and the Board concludes as a result that it is essential to defer the filing of such Registration Statement or the undertaking of such Underwritten Offering at such time, then in each case the Company shall furnish to such
Holders a certificate signed by the Chairman of the Board stating that in the good faith judgment of the majority of the Board it would be seriously detrimental to the Company for such Registration Statement to be filed or to undertake such
Underwritten Offering in the near future and that it is therefore essential to defer the filing of such Registration Statement or undertaking of such Underwritten Offering. In such event, the Company shall have the right to defer such filing or
offering for a period of not more than thirty (30) days; provided, however, that the Company shall not defer its obligation in this manner more than once in any twelve (12)-month period. 

ARTICLE III 
 COMPANY
PROCEDURES 
 3.1    General Procedures. The Company shall use its commercially reasonable efforts to effect
such Registration to permit the sale of such Registrable Securities in accordance with the intended plan of distribution thereof, and pursuant thereto the Company shall, as expeditiously as possible and to the extent applicable: 

  
 7 

 3.1.1    prepare and file with the Commission, within the time frame
required by Section 2.1.1, a Registration Statement with respect to such Registrable Securities and use its commercially reasonable efforts to cause such Registration Statement to become effective and remain effective, including filing a
replacement Registration Statement, if necessary, until all Registrable Securities covered by such Registration Statement have been sold or are no longer outstanding (such period, the “Effectiveness Period”); 

3.1.2    prepare and file with the Commission such amendments and post-effective amendments to the Registration Statement,
and such supplements to the Prospectus, as may be reasonably requested by the Demanding Holders or any Underwriter or as may be required by the rules, regulations or instructions applicable to the registration form used by the Company or by the
Securities Act or rules and regulations thereunder to keep the Registration Statement effective until all Registrable Securities covered by such Registration Statement are sold in accordance with the intended plan of distribution set forth in such
Registration Statement or supplement to the Prospectus or are no longer outstanding; 
 3.1.3    prior to filing a
Registration Statement or Prospectus, or any amendment or supplement thereto, furnish without charge to the Underwriters or Financial Counterparty, if any, and the Holders of Registrable Securities included in such Registration or Underwritten
Offering or Block Trade, and such Holders’ legal counsel, copies of such Registration Statement as proposed to be filed, each amendment and supplement to such Registration Statement (in each case including all exhibits thereto and documents
incorporated by reference therein), the Prospectus (including each preliminary Prospectus) and such other documents as the Underwriters and the Holders of Registrable Securities included in such Registration or the legal counsel for any such Holders
may reasonably request in order to facilitate the disposition of the Registrable Securities owned by such Holders; provided, that the Company will not have any obligation to provide any document pursuant to this clause that is available on
the Commission’s EDGAR system; 
 3.1.4    prior to any Registration of Registrable Securities, use its
commercially reasonable efforts to (i) register or qualify the Registrable Securities covered by the Registration Statement under such securities or “blue sky” laws of such jurisdictions in the United States as the Holders of
Registrable Securities included in such Registration Statement (in light of their intended plan of distribution) may request and (ii) take such action necessary to cause such Registrable Securities covered by the Registration Statement to be
registered with or approved by such other governmental authorities as may be necessary by virtue of the business and operations of the Company and do any and all other acts and things that may be necessary or advisable to enable the Holders of
Registrable Securities included in such Registration Statement to consummate the disposition of such Registrable Securities in such jurisdictions; provided, however, that the Company shall not be required to qualify generally to do business
in any jurisdiction where it would not otherwise be required to qualify or take any action to which it would be subject to general service of process or taxation in any such jurisdiction where it is not then otherwise so subject; 

3.1.5    cause all such Registrable Securities to be listed on each securities exchange or automated quotation system on
which similar securities issued by the Company are then listed; 
 3.1.6    provide a transfer agent or warrant agent,
as applicable, and registrar for all such Registrable Securities no later than the effective date of such Registration Statement; 

3.1.7    advise each seller of such Registrable Securities, promptly after it shall receive notice or obtain knowledge
thereof, of the issuance of any stop order by the Commission suspending the effectiveness of such Registration Statement or the initiation or threatening of any proceeding for such purpose and promptly use its commercially reasonable efforts to
prevent the issuance of any stop order or to obtain its withdrawal if such stop order should be issued; 

3.1.8    during the Effectiveness Period, furnish a conformed copy of each filing of any Registration Statement or
Prospectus or any amendment or supplement to such Registration Statement or Prospectus or any document that is to be incorporated by reference into such Registration Statement or Prospectus, promptly after such filing of such documents with the
Commission to each seller of such Registrable Securities or its counsel; provided, that the Company will not have any obligation to provide any document pursuant to this clause that is available on the Commission’s EDGAR system; 

  
 8 

 3.1.9    notify the Holders at any time when a Prospectus relating to
such Registration Statement is required to be delivered under the Securities Act; 
 3.1.10    in accordance with
Section 3.4 of this Agreement of this Agreement, notify the Holders of the happening of any event as a result of which a Misstatement exists, and then to correct such Misstatement as set forth in Section 3.4 of this
Agreement; 
 3.1.11    in the event of an Underwritten Offering, a Block Trade, an Other Coordinated Offering, or sale
by a Financial Counterparty pursuant to such Registration, permit a representative of the Holders (such representative to be selected by a majority of the Holders), the Underwriters or other Financial Counterparty facilitating such Underwritten
Offering, a Block Trade, Other Coordinated Offering or other sale pursuant to such Registration, if any, and any attorney, consultant or accountant retained by such Holders or Underwriter to participate, at each such person’s or entity’s
own expense, in the preparation of the Registration Statement or the Prospectus, and cause the Company’s officers, directors and employees to supply all information reasonably requested by any such representative, Underwriter, Financial
Counterparty, attorney, consultant or accountant in connection with the Registration; provided, however, that such representatives or Underwriters or Financial Counterparty enter to confidentiality agreements, in form and substance reasonably
satisfactory to the Company, prior to the release or disclosure of any such information; 
 3.1.12    obtain a comfort
letter from the Company’s independent registered public accountants in the event of an Underwritten Offering, a Block Trade, an Other Coordinated Offering or sale by a Financial Counterparty pursuant to such Registration (subject to such
Financial Counterparty providing such certification or representation reasonably requested by the Company’s independent registered public accountants and the Company’s counsel), in customary form and covering such matters of the type
customarily covered by comfort letters as the managing Underwriter may reasonably request, and reasonably satisfactory to a majority-in-interest of the participating Holders; 

3.1.13    in the event of an Underwritten Offering, a Block Trade, an Other Coordinated Offering or sale by a Financial
Counterparty pursuant to such Registration, on the date the Registrable Securities are delivered for sale pursuant to such Registration, obtain an opinion, dated such date, of counsel representing the Company for the purposes of such Registration,
addressed to the participating Holders or the Financial Counterparty, if any, and the Underwriters, if any, covering such legal matters with respect to the Registration in respect of which such opinion is being given as the participating Holders,
Financial Counterparty or Underwriter may reasonably request and as are customarily included in such opinions and negative assurance letters, and reasonably satisfactory to such participating Holders, Financial Counterparty or Underwriter; 

3.1.14    in the event of an Underwritten Offering or a Block Trade, or an Other Coordinated Offering or sale by a
Financial Counterparty pursuant to such Registration to which the Company has consented, to the extent reasonably requested by such Financial Counterparty in order to engage in such offering, allow the Underwriters or Financial Counterparty to
conduct customary “underwriter’s due diligence” with respect to the Company; 
 3.1.15    in the event of
any Underwritten Offering, a Block Trade, an Other Coordinated Offering or sale by a Financial Counterparty pursuant to such Registration, enter into and perform its obligations under an underwriting agreement or other purchase or sales agreement,
in usual and customary form, with the managing Underwriter or the Financial Counterparty of such offering or sale; 

3.1.16    make available to its security holders, as soon as reasonably practicable, an earnings statement covering the
period of at least twelve (12) months beginning with the first day of the Company’s first full calendar quarter after the effective date of the Registration Statement which satisfies the provisions of Section 11(a) of the Securities
Act and Rule 158 thereunder (or any successor rule promulgated thereafter by the Commission); 
 3.1.17    if the
Registration involves the Registration of Registrable Securities in an Underwritten Offering in excess of the Minimum Amount, use its reasonable efforts to make available senior executives of the Company to participate in customary “road
show” presentations that may be reasonably requested by the Underwriter in any Underwritten Offering; and 

  
 9 

 3.1.18    otherwise, in good faith, cooperate reasonably with, and take
such customary actions as may reasonably be requested by the Holders, in connection with such Registration. 
 Notwithstanding the foregoing, the Company
shall not be required to provide any documents or information to an Underwriter or Financial Counterparty if such Underwriter or Financial Counterparty has not then been named with respect to the applicable Underwritten Offering or other offering
involving a registration as an Underwriter or Financial Counterparty, as applicable. 
 3.2    Registration
Expenses. The Registration Expenses in respect of all Registrations shall be borne by the Company. It is acknowledged by the Holders that the Holders shall bear all incremental selling expenses relating to the sale of Registrable Securities,
such as Underwriters’ commissions and discounts, brokerage fees, Underwriter marketing costs and, other than as set forth in the definition of “Registration Expenses,” all reasonable fees and expenses of any legal counsel representing
the Holders. 
 3.3    Requirements for Participation in Underwritten Offerings. No person may participate in any
Underwritten Offering for equity securities of the Company pursuant to a Registration initiated by the Company hereunder unless such person (i) agrees to sell such person’s securities on the basis provided in any underwriting arrangements
approved by the Company and (ii) completes and executes all customary questionnaires, powers of attorney, indemnities, lock-up agreements, underwriting agreements and other customary documents as may be
reasonably required under the terms of such underwriting arrangements. 
 3.4    Suspension of Sales.
Notwithstanding anything to the contrary in this Agreement, the Company shall be entitled to (A) delay or postpone the (i) initial effectiveness of any Registration Statement or (ii) launch of any Underwritten Offering, in each case,
filed or requested pursuant to this Agreement, and (B) from time to time to require the Holders not to sell under any Registration Statement or Prospectus or to suspend the effectiveness thereof, if the negotiation or consummation of a
transaction by the Company or its subsidiaries is pending or an event has occurred, which negotiation, consummation or event, the Board reasonably believes, upon the advice of legal counsel, would require additional disclosure by the Company in the
applicable Registration Statement or Prospectus of material information that the Company has a bona fide business purpose for keeping confidential and the non-disclosure of which in the Registration Statement
or Prospectus would be expected, in the reasonable determination of the Board, upon the advice of legal counsel, to cause the Registration Statement or Prospectus to fail to comply with applicable disclosure requirements (each such circumstance, a
“Suspension Event”); provided, however, that the Company may not delay or suspend a Registration Statement, Prospectus or Underwritten Offering on more than two occasions, for more than sixty (60) consecutive calendar
days, or more than ninety (90) total calendar days, in each case during any twelve-month period. Upon receipt of any written notice from the Company of a Suspension Event while a Registration Statement filed pursuant to this Agreement is
effective or if as a result of a Suspension Event a Misstatement exists, each Holder agrees that (i) it will immediately discontinue offers and sales of Registered Securities under each Registration Statement filed pursuant to this Agreement
until the Holder receives copies of a supplemental or amended Prospectus (which the Company agrees to promptly prepare) that corrects the relevant misstatements or omissions and receives notice that any post-effective amendment has become effective
or unless otherwise notified by the Company that it may resume such offers and sales and (ii) it will maintain the confidentiality of information included in such written notice delivered by the Company unless otherwise required by law or
subpoena. If so directed by the Company, the Holders will deliver to the Company or, in Holders’ sole discretion destroy, all copies of each Prospectus covering Registrable Securities in Holders’ possession; provided, however, that this
obligation to deliver or destroy shall not apply (A) to the extent the Holders are required to retain a copy of such Prospectus (x) to comply with applicable legal, regulatory, self-regulatory or professional requirements or (y) in
accordance with a bona fide pre-existing document retention policy or (B) to copies stored electronically on archival servers as a result of automatic data back-up.

 3.5    Reporting Obligations. As long as any Holder shall own Registrable Securities, the Company, at all
times while it shall be a reporting company under the Exchange Act, covenants to file timely (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof
pursuant to Section 13(a) or 15(d) of the Exchange Act. The Company further covenants that it shall take such further action as any Holder may reasonably request, all to the extent required from time to time to enable such Holder to sell shares
of Registrable Securities held by such Holder without registration under the Securities Act within the limitation of the exemptions provided by Rule 144 promulgated under the Securities Act (or any successor rule promulgated thereafter by the
Commission), including providing any legal opinions. Upon the request of any Holder, the Company shall deliver to such Holder a written certification of a duly authorized officer as to whether it has complied with such requirements. 

  
 10 

 ARTICLE IV 

INDEMNIFICATION AND CONTRIBUTION 

4.1    Indemnification. 

4.1.1    The Company agrees to indemnify, to the extent permitted by law, each Holder of Registrable Securities, its
officers and directors and each person who controls such Holder (within the meaning of the Securities Act) (collectively, the “Holder Indemnified Persons”) against all losses, claims, damages, liabilities and out-of-pocket expenses (including reasonable outside attorneys’ fees and inclusive of all reasonable outside attorneys’ fees arising out of the enforcement of each
such persons’ rights under this Section 4.1) resulting from any Misstatement or alleged Misstatement, except insofar as the same are caused by or contained in any information furnished in writing to the Company by or on behalf of
such Holder Indemnified Person specifically for use therein. 
 4.1.2    In connection with any Registration Statement
in which a Holder of Registrable Securities is participating, such Holder shall furnish to the Company in writing such information and affidavits as the Company reasonably requests for use in connection with any such Registration Statement or
Prospectus and, to the extent permitted by law, shall, severally and not jointly, indemnify the Company, its directors and officers and agents and each person who controls the Company (within the meaning of the Securities Act) against any losses,
claims, damages, liabilities and out-of-pocket expenses (including reasonable outside attorneys’ fees and inclusive of all reasonable outside attorneys’ fees
arising out of the enforcement of each such persons’ rights under this Section 4.1) resulting from any Misstatement or alleged Misstatement, but only to the extent that the same are made in reliance on and in conformity with
information relating to the Holder so furnished in writing to the Company by or on behalf of such Holder specifically for use therein. In no event shall the liability of any selling Holder hereunder be greater in amount than the net proceeds
received by such Holder from the sale of Registrable Securities pursuant to such Registration Statement giving rise to such indemnification obligation. 

4.1.3    Any person entitled to indemnification herein shall (i) give prompt written notice to the indemnifying party
of any claim with respect to which it seeks indemnification (provided that the failure to give prompt notice shall not impair any person’s right to indemnification hereunder to the extent such failure has not materially prejudiced the
indemnifying party) and (ii) unless in such indemnified party’s reasonable judgment a conflict of interest between such indemnified and indemnifying parties may exist with respect to such claim or there may be reasonable defenses available
to the indemnified party that are different from or additional to those available to the indemnifying party, permit such indemnifying party to assume the defense of such claim with counsel reasonably satisfactory to the indemnified party. If such
defense is assumed, the indemnifying party shall not be subject to any liability for any settlement made by the indemnified party without its consent (but such consent shall not be unreasonably withheld). An indemnifying party who is not entitled
to, or elects not to, assume the defense of a claim shall not be obligated to pay the fees and expenses of more than one outside counsel for all parties indemnified by such indemnifying party with respect to such claim, unless in the reasonable
judgment of any indemnified party a conflict of interest may exist between such indemnified party and any other of such indemnified parties with respect to such claim. No indemnifying party shall, without the consent of the indemnified party,
consent to the entry of any judgment or enter into any settlement which cannot be settled in all respects by the payment of money (and such money is so paid by the indemnifying party pursuant to the terms of such settlement) or which settlement does
not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party of a release from all liability in respect to such claim or litigation. 

4.1.4    The indemnification provided for under this Agreement shall remain in full force and effect regardless of any
investigation made by or on behalf of the indemnified party or any officer, director or controlling person of such indemnified party and shall survive the transfer of securities. 

4.1.5    If the indemnification provided under Section 4.1 of this Agreement is held by a court of competent
jurisdiction to be unavailable to an indemnified party in respect of any losses, claims, damages, liabilities and expenses referred to herein, then the indemnifying party, in lieu of indemnifying the indemnified party, shall to the extent permitted
by law contribute to the amount paid or payable by the indemnified party as a result of such losses, claims, damages, liabilities and expenses in such proportion as is appropriate to reflect the relative fault of the

  
 11 

 
indemnifying party and the indemnified party, as well as any other relevant equitable considerations. The relative fault of the indemnifying party and indemnified party shall be determined by a
court of law by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by such indemnifying party or such
indemnified party and the indemnifying party’s and indemnified party’s relative intent, knowledge, access to information and opportunity to correct or prevent such action; provided, however, that the liability of any Holder under
this subsection 4.1.5 shall be limited to the amount of the net proceeds received by such Holder in such offering giving rise to such liability. The amount paid or payable by a party as a result of the losses or other liabilities referred to
above shall be deemed to include, subject to the limitations set forth in subsections 4.1.1, 4.1.2 and 4.1.3 of this Agreement, any legal or other fees, charges or
out-of-pocket expenses reasonably incurred by such party in connection with any investigation or proceeding. The parties hereto agree that it would not be just and
equitable if contribution pursuant to this subsection 4.1.5 were determined by pro rata allocation or by any other method of allocation, which does not take account of the equitable considerations referred to in this subsection 4.1.5.
No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution pursuant to this subsection 4.1.5 from any person who was not guilty of such fraudulent
misrepresentation. 
 ARTICLE V 

MISCELLANEOUS 

5.1    Notices. Any notice or communication under this Agreement must be in writing and given by (i) deposit
in the United States mail, addressed to the party to be notified, postage prepaid and registered or certified with return receipt requested, (ii) delivery in person or by courier service providing evidence of delivery or (iii) transmission
by hand delivery, telecopy, telegram, facsimile or email. Each notice or communication that is mailed, delivered or transmitted in the manner described above shall be deemed sufficiently given, served, sent, and received, in the case of mailed
notices, on the third (3rd) business day following the date on which it is mailed, in the case of notices delivered by courier service, hand delivery, telecopy or telegram, at such time as it is delivered to the addressee (with the delivery receipt
or the affidavit of messenger) or at such time as delivery is refused by the addressee upon presentation, and in the case of notices delivered by facsimile or email, at such time as it is successfully transmitted to the addressee. Any notice or
communication under this Agreement must be addressed, if to the Sponsor, to: 2744 Sand Hill Road, Menlo Park, CA 94025, or by email at: phaskopoulos@riverstonellc.com, if to the Company, to: 48 Miller Street, MURARRIE, QLD 4172, Australia,
Attention: Mark Anning, or by email at: manning@tritium.com.au, and, if to any Holder, to the address of such Holder as it appears in the applicable register for the Registrable Securities or such other address as may be designated in writing by
such Holder (including on the signature pages hereto). Any party may change its address for notice at any time and from time to time by written notice to the other parties hereto, and such change of address shall become effective thirty
(30) days after delivery of such notice as provided in this Section 5.1. 
 5.2    Assignment; No
Third Party Beneficiaries. 
 5.2.1    This Agreement and the rights, duties and obligations of the Company
hereunder may not be assigned or delegated by the Company in whole or in part. 
 5.2.2    This Agreement and the
provisions hereof shall be binding upon and shall inure to the benefit of each of the parties and its successors. 

5.2.3    This Agreement shall not confer any rights or benefits on any persons that are not parties hereto or do not
hereafter become a party to this Agreement pursuant to Section 5.2 of this Agreement. 
 5.2.4    No
assignment by any party hereto of such party’s rights, duties and obligations hereunder shall be binding upon or obligate the Company unless and until the Company shall have received (i) written notice provided in accordance with
Section 5.1 of this Agreement and (ii) the written agreement of the assignee, in a form reasonably satisfactory to the Company, to be bound by the terms and provisions of this Agreement (which may be accomplished by an addendum or
certificate of joinder to this Agreement). Any transfer or assignment made other than as provided in this Section 5.2 shall be null and void. 

  
 12 

 5.3    Counterparts. This Agreement may be executed in multiple
counterparts (including facsimile or PDF counterparts), each of which shall be deemed an original, and all of which together shall constitute the same instrument, but only one of which need be produced. 

5.4    Governing Law; Venue. NOTWITHSTANDING THE PLACE WHERE THIS AGREEMENT MAY BE EXECUTED BY ANY OF THE PARTIES
HERETO, THE PARTIES EXPRESSLY AGREE THAT THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED UNDER THE LAWS OF THE STATE OF NEW YORK AS APPLIED TO AGREEMENTS AMONG NEW YORK RESIDENTS ENTERED INTO AND TO BE PERFORMED ENTIRELY WITHIN NEW YORK, WITHOUT
REGARD TO THE CONFLICT OF LAW PROVISIONS OF SUCH JURISDICTION. 
 5.5    Amendments and Modifications. Upon the
written consent of the Company and the Holders of at least a majority in interest of the total Registrable Securities at the time in question, compliance with any of the provisions, covenants and conditions set forth in this Agreement may be waived,
or any of such provisions, covenants or conditions may be amended or modified; provided, however, that notwithstanding the foregoing, any amendment hereto or waiver hereof that adversely affects one Holder, solely in his, her or its capacity
as a holder of the shares of capital stock of the Company, in a manner that is materially different from the other Holders (in such capacity) shall require the consent of the Holder so affected. No course of dealing between any Holder or the Company
and any other party hereto or any failure or delay on the part of a Holder or the Company in exercising any rights or remedies under this Agreement shall operate as a waiver of any rights or remedies of any Holder or the Company. No single or
partial exercise of any rights or remedies under this Agreement by a party shall operate as a waiver or preclude the exercise of any other rights or remedies hereunder or thereunder by such party. 

5.6    Other Registration Rights. The Company represents and warrants that no person, other than (a) a Holder
of Registrable Securities, (b) the holders of the Company’s warrants pursuant to that certain Warrant Agreement, dated as of February 3, 2021, by and between the SPAC and Continental Stock Transfer & Trust Company, and
assigned to and assumed by the Company, Computershare Inc. and its wholly owned subsidiary, Computershare Trust Company, N.A., on or about the date hereof, and (c) Palantir Technologies Inc., pursuant to its Subscription Agreement with the
Company and the SPAC, dated as of July 27, 2021 (as amended), has any right to require the Company to register any securities of the Company for sale or to include such securities of the Company in any Registration filed by the Company for the
sale of securities for its own account or for the account of any other person. Further, the Company represents and warrants that this Agreement supersedes any other registration rights agreement, including the SPAC Registration Rights Agreement, or
agreement with similar terms and conditions and in the event of a conflict between any such agreement or agreements and this Agreement, the terms of this Agreement shall prevail. 

5.7    Term. This Agreement shall terminate upon the earlier of (i) the tenth (10th) anniversary of the date
of this Agreement and (ii) with respect to any Holder, the date as of which such Holder ceases to hold any Registrable Securities. The provisions of Article IV shall survive any termination. 

[SIGNATURE PAGES FOLLOW] 

  
 13 

 IN WITNESS WHEREOF, the undersigned have caused this Agreement to be executed as of
the date first written above. 
  

			
	COMPANY:
	
	 TRITIUM DCFC LIMITED,
 an
Australian public company

		
	By:	 	 /s/ Mark Anning

		 	Name: Mark Anning
		 	Title: Secretary

 [Signature Page to Registration Rights Agreement] 

 
			
	SPAC:
	
	 DECARBONIZATION PLUS ACQUISITION CORPORATION II,

a Delaware corporation

		
	By:        	 	 /s/ Peter Haskopoulos

		 	Name: Peter Haskopoulos
		 	Title:   Chief Financial Officer, Chief Accounting Officer and Secretary
	
	HOLDERS:
	
	DECARBONIZATION PLUS ACQUISITION SPONSOR II, LLC,
	a Delaware limited liability company
	
	By: Decarbonization Plus Acquisition Sponsor Manager II, LLC, its Managing Member
		
	By:	 	 /s/ Peter Haskopoulos

		 	Name: Peter Haskopoulos
		 	Title: Authorized Person

 [Signature Page to Registration Rights Agreement] 

 
	
	 /s/ James AC McDermott

	James AC McDermott

 [Signature Page to Registration Rights Agreement] 

 
	
	 /s/ Jeffrey Tepper

	Jeffrey Tepper

 [Signature Page to Registration Rights Agreement] 

 
	
	 /s/ Dr. Jennifer Aaker

	Dr. Jennifer Aaker

 [Signature Page to Registration Rights Agreement] 

 
	
	 /s/ Jane Kearns

	 Jane Kearns

 [Signature Page to Registration Rights Agreement] 

 IN WITNESS WHEREOF, the undersigned have caused this Agreement to be executed as of
the date first written above. 
 HOLDERS: 
  

					
	Executed by each Holder, who is listed on the Schedule which immediately follows this signature page by its attorneys, who declares that they have received no notice of revocation of that power of attorney, in the presence
of:	 		 	
			
	 /s/ Mark Anning
	 	            	 	 /s/ Trevor St. Baker

	Signature of witness	 		 	Signature of attorney
			
	 Mark Anning
	 		 	 Trevor St. Baker

	Full name of witness	 		 	Full name of attorney
			
	 /s/ Mark Anning
	 		 	 /s/ David Finn

	Signature of witness	 		 	Signature of attorney
			
	 Mark Anning
	 		 	 David Finn

	Full name of witness	 		 	Full name of attorney

 [Signature Page to Registration Rights Agreement] 

 SCHEDULE 
  

							
	 No.
	  	 Holder
	  	 Address
	  	 Email Address

				
	1.	  	St Baker Energy Holdings Pty Ltd ATF St Baker Energy Innovation Trust	  		  	
				
	2.	  	Varley Holdings Pty. Limited	  		  	
				
	3.	  	GGC International Holdings LLC	  		  	
				
	4.	  	Ilwella Pty Ltd	  		  	
				
	5.	  	Finnmax Pty Ltd ATF Finn Family Trust	  		  	
				
	6.	  	James Kennedy ATF Kennedy Family Trust	  		  	
				
	7.	  	Sernik Pty Ltd ATF Sernia Family Trust	  		  	
				
	8.	  	Bernard Brian Walsh	  		  	
				
	9.	  	Geoffrey Ralph Walker	  		  	
				
	10.	  	LRSR Pty Ltd ATF Beaumont Investment Trust	  		  	
				
	11.	  	Mariva Investments Pty Ltd ATF Mariva Property Trust	  		  	
				
	12.	  	Panic Super Pty Ltd ATF Panic Superannuation Fund	  		  	
				
	13.	  	Franunta Super Pty Ltd ATF Franunta Superannuation Fund	  		  	
				
	14.	  	Opnet Pty Ltd ATF The Opnet Trust	  		  	
				
	15.	  	Greengrid Investment Holding Group Pty Ltd	  		  	
				
	16.	  	Retail Bids Limited	  		  	
				
	17.	  	Elda Electronics Pty Ltd	  		  	

							
	 No.
	  	 Holder
	  	 Address
	  	 Email Address

				
	18.	  	Grenning Family Super Pty Ltd ATF Grenning Family Superannuation Fund	  		  	
				
	19.	  	Dana Nicole Murphy ATF Banbury Place Investment Trust	  		  	
				
	20.	  	Thimios Super Pty Ltd ATF Thimios Superannuation Fund	  		  	
				
	21.	  	Tambleview Pty Ltd ATF Tambleview Property Trust	  		  	
				
	22.	  	Morris Equity Investments Pty Ltd ATF The KDLM Trust Account	  		  	
				
	23.	  	BS & PL McSweeney Pty Ltd ATF McSweeneys Pharmacy Superannuation Fund No 2	  		  	
				
	24.	  	Joseph Lelkes	  		  	
				
	25.	  	Ballachanda Vikram Cariappa	  		  	
				
	26.	  	Lars Christer Wille	  		  	
				
	27.	  	Michael Walton and Cho Walton	  		  	
				
	28.	  	Brendan Pearce	  		  	
				
	29.	  	Siew Ben Wong	  		  	
				
	30.	  	Ashley Scott Ballinger	  		  	
				
	31.	  	Satya Devanand Verma	  		  	
				
	32.	  	Alexander Rudzki	  		  	
				
	33.	  	Christopher Crossman	  		  	
				
	34.	  	Dion Sumpton	  		  	
				
	35.	  	Michael Walton	  		  	

  
 page 2 

							
	 No.
	  	 Holder
	  	 Address
	  	 Email Address

				
	36.	  	Peter Coe	  		  	
				
	37.	  	Sherwin Bell	  		  	
				
	38.	  	Shelley Farrell	  		  	
				
	39.	  	Calem Walsh	  		  	
				
	40.	  	Marcelo Salgado	  		  	
				
	41.	  	David Toomey ATF David James Toomey Family Trust	  		  	
				
	42.	  	Luke Hovington	  		  	
				
	43.	  	Peter Earl	  		  	
				
	44.	  	Jordan Pierce	  		  	
				
	45.	  	Paul McWilliams	  		  	
				
	46.	  	Xavier Casley	  		  	
				
	47.	  	Francis Viviers	  		  	
				
	48.	  	Cameron Swales	  		  	
				
	49.	  	David Blum	  		  	
				
	50.	  	Matthew Finn	  		  	
				
	51.	  	Tobias Sonnenburg	  		  	
				
	52.	  	Michael Russo	  		  	
				
	53.	  	Michael Boylson ATF Boylson Trust	  		  	

  
 page 3 

							
	 No.
	  	 Holder
	  	 Address
	  	 Email Address

				
	54.	  	Daniel Stephen Kermode	  		  	
				
	55.	  	Gunasiri Family Super Pty Ltd ATF Gunasiri Family Super Fund	  		  	
				
	56.	  	Beata Grzegorczyk	  		  	
				
	57.	  	Paul Hewitt	  		  	
				
	58.	  	Nicholas Ockhuisen	  		  	
				
	59.	  	Bikash Pandey	  		  	
				
	60.	  	Lili Zhang	  		  	
				
	61.	  	Bradley Alan Cran	  		  	
				
	62.	  	Stefan Gotz	  		  	
				
	63.	  	Peter Blyth	  		  	
				
	64.	  	Ben Guymer	  		  	
				
	65.	  	Yi Tang	  		  	
				
	66.	  	Mao Li	  		  	
				
	67.	  	Arron Lee	  		  	
				
	68.	  	Richard Kosik	  		  	
				
	69.	  	Jeroen Jonker	  		  	
				
	70.	  	James Greg Lary	  		  	
				
	71.	  	Cindy Carruthers	  		  	

  
 page 4 

							
	 No.
	  	 Holder
	  	 Address
	  	 Email Address

				
	72.	  	Dennis Pascual and Carolyn Pascual	  		  	
				
	73.	  	Dion Schulz	  		  	
				
	74.	  	Manuel Fernandes	  		  	
				
	75.	  	Daniel McInnes	  		  	
				
	76.	  	Stephen James	  		  	
				
	77.	  	Harrison Hume	  		  	
				
	78.	  	Tom Fraser	  		  	
				
	79.	  	Bill McKay-Lowndes	  		  	
				
	80.	  	Sean Giuricin	  		  	
				
	81.	  	Grant Kennedy	  		  	
				
	82.	  	Alana Churchward	  		  	
				
	83.	  	Daniel Kerr	  		  	
				
	84.	  	Jason Wayenberg	  		  	
				
	85.	  	Eileen Chan Kee	  		  	
				
	86.	  	Nasir Basha	  		  	
				
	87.	  	Toatele Siulai	  		  	
				
	88.	  	Chuan Hsien Hung	  		  	
				
	89.	  	Wayne Blair	  		  	

  
 page 5 

							
	 No.
	  	 Holder
	  	 Address
	  	 Email Address

				
	90.	  	Jake Arnold	  		  	
				
	91.	  	Cameron McDougall	  		  	
				
	92.	  	Vinay Kumar	  		  	
				
	93.	  	Brooke Nyman	  		  	
				
	94.	  	Vikram Gill	  		  	
				
	95.	  	Eliezer Pasno	  		  	
				
	96.	  	Richard Abarintos	  		  	
				
	97.	  	Raza Aftab	  		  	
				
	98.	  	Jason Bray	  		  	
				
	99.	  	Paul Burnett	  		  	
				
	100.	  	Asad Riaz	  		  	
				
	101.	  	Eglicila De Leiuen	  		  	
				
	102.	  	Easter Faamatuainu	  		  	
				
	103.	  	Darryl Haslet	  		  	
				
	104.	  	Rajib Paul	  		  	
				
	105.	  	Dianne Poynter	  		  	
				
	106.	  	Siolo Pule	  		  	
				
	107.	  	Emmanuel Ramirez	  		  	

  
 page 6 

							
	 No.
	  	 Holder
	  	 Address
	  	 Email Address

				
	108.	  	Martin Rohde	  		  	
				
	109.	  	Dominic Russo	  		  	
				
	110.	  	Dick Sen	  		  	
				
	111.	  	Michelle Stevenson	  		  	
				
	112.	  	Melanie Dooley	  		  	
				
	113.	  	Michael Vagg	  		  	
				
	114.	  	Michael Boylson	  		  	
				
	115.	  	Seshan Weeratunga	  		  	
				
	116.	  	Shen Xie	  		  	
				
	117.	  	Ger Yang	  		  	
				
	118.	  	David Toomey	  		  	
				
	119.	  	Hinton Holdings (Australia) Pty Ltd ATF Paton Family Superannuation Fund	  		  	
				
	120.	  	Tri-Anta Pty Ltd ATF The Rose Family Trust	  		  	
				
	121.	  	Fabbrostone Pty Ltd	  		  	
				
	122.	  	Rostfay Pty Ltd ATF Tritium Unit Trust	  		  	
				
	123.	  	Isabella Pennefather Pty Ltd	  		  	
				
	124.	  	Coolah Holdings Pty Ltd ATF The Lambert Family Trust	  		  	
				
	125.	  	Big Bucket Car Wash Pty Ltd ATF Miller Owen Family Trust	  		  	

  
 page 7 

							
	 No.
	  	 Holder
	  	 Address
	  	 Email Address

				
	126.	  	Simon and Zena Clark ATF Size Super Fund	  		  	
				
	127.	  	Simon Clark and Zena Clark	  		  	
				
	128.	  	Robert Llewellyn Davies	  		  	
				
	129.	  	DB & MJ Overell ATF Overell Superannuation Fund	  		  	
				
	130.	  	Elizabeth Abegg Pty Ltd	  		  	
				
	131.	  	New Lake 10 BV	  		  	
				
	132.	  	Jezal Securities Pty Ltd	  		  	
				
	133.	  	Wholesale Diving Supplies Pty Ltd	  		  	
				
	134.	  	Ian McBain Holland	  		  	
				
	135.	  	S.M. Robinson PAF Pty Ltd	  		  	
				
	136.	  	Warringah Theatres Pty Ltd	  		  	
				
	137.	  	Aidan Clarke	  		  	
				
	138.	  	Brandon Barron	  		  	
				
	139.	  	Brett Meredith	  		  	
				
	140.	  	Jacoba Gerritsen	  		  	
				
	141.	  	Harry Watson	  		  	
				
	142.	  	James Martin	  		  	
				
	143.	  	Kei Nakahara	  		  	

  
 page 8 

							
	 No.
	  	 Holder
	  	 Address
	  	 Email Address

				
	144.	  	Mark Anning	  		  	
				
	145.	  	Michelle Lofthouse	  		  	
				
	146.	  	Nicholas Keeling	  		  	
				
	147.	  	Paul Forbes	  		  	
				
	148.	  	Rachel Walsh	  		  	
				
	149.	  	Stephan Sommerschuh	  		  	
				
	150.	  	Timo Bellgardt	  		  	
				
	151.	  	Todd Lamb	  		  	
				
	152.	  	Jane Hunter	  		  	
				
	153.	  	Michael Hipwood	  		  	
				
	154.	  	Nicholas Coghlan	  		  	
				
	155.	  	Celine Roche	  		  	
				
	156.	  	Arvin Lobo	  		  	
				
	157.	  	Aaron Palm	  		  	
				
	158.	  	Adrian Santos	  		  	
				
	159.	  	Archana Singh	  		  	
				
	160.	  	Berto Di Pasquale	  		  	
				
	161.	  	Bishoy Garas	  		  	

  
 page 9 

							
	 No.
	  	 Holder
	  	 Address
	  	 Email Address

				
	162.	  	Brie’Anna Ihle	  		  	
				
	163.	  	Byung Guk Kim	  		  	
				
	164.	  	Brigitte Kirk	  		  	
				
	165.	  	Brendan O’Brien	  		  	
				
	166.	  	Chirag Kheni	  		  	
				
	167.	  	Cathie Seed	  		  	
				
	168.	  	Christopher Watts	  		  	
				
	169.	  	Emmanuel Abellana	  		  	
				
	170.	  	Emelita Newton	  		  	
				
	171.	  	Ester Ranson	  		  	
				
	172.	  	Eric Talatonu	  		  	
				
	173.	  	Fabio Mureddu	  		  	
				
	174.	  	Gavin Reid	  		  	
				
	175.	  	Isaac Dimanstein	  		  	
				
	176.	  	Jessica Castro	  		  	
				
	177.	  	Jeanette Choi	  		  	
				
	178.	  	John Gorman	  		  	
				
	179.	  	Janaka Weerathunga Yapa Seneviratne	  		  	

  
 page 10 

							
	 No.
	  	 Holder
	  	 Address
	  	 Email Address

				
	180.	  	Jainandra Sharma	  		  	
				
	181.	  	Jack Siaki	  		  	
				
	182.	  	Janelle Walker	  		  	
				
	183.	  	Karl Erakovic	  		  	
				
	184.	  	Katherine Molloy	  		  	
				
	185.	  	Karen Smetzer	  		  	
				
	186.	  	Leah Hodgkinson	  		  	
				
	187.	  	Linda Turner	  		  	
				
	188.	  	Melinda Batley-Ole Keko	  		  	
				
	189.	  	Menchie Findling	  		  	
				
	190.	  	Mitchell Paul	  		  	
				
	191.	  	Mario Punzalan	  		  	
				
	192.	  	Michael Robinson	  		  	
				
	193.	  	Massoud Sabzali	  		  	
				
	194.	  	Morgan Welch	  		  	
				
	195.	  	Norlito Apiado Corpuz	  		  	
				
	196.	  	Peter Brighouse	  		  	
				
	197.	  	Phuoc Tran	  		  	

  
 page 11 

							
	 No.
	  	 Holder
	  	 Address
	  	 Email Address

				
	198.	  	Rohit Darodkar	  		  	
				
	199.	  	Rajesh Mohanrajvetrivel	  		  	
				
	200.	  	Raina Peta	  		  	
				
	201.	  	Rodolfo Tarroja	  		  	
				
	202.	  	Ravina Tong	  		  	
				
	203.	  	Ryan Watson	  		  	
				
	204.	  	Suresh Kumar Parthibhan	  		  	
				
	205.	  	Shelley Palmer	  		  	
				
	206.	  	Sharon Pulford	  		  	
				
	207.	  	Sugandha Sahdev	  		  	
				
	208.	  	Scott Sullivan	  		  	
				
	209.	  	Sandi Tolic	  		  	
				
	210.	  	Sherwin Upao	  		  	
				
	211.	  	Jinling Jiang	  		  	
				
	212.	  	Trung Thanh Le	  		  	
				
	213.	  	Thushan Viswakula	  		  	
				
	214.	  	Vijayachandran Balachandra	  		  	
				
	215.	  	Veronika Squires	  		  	

  
 page 12 

							
	 No.
	  	 Holder
	  	 Address
	  	 Email Address

				
	216.	  	William Bernard	  		  	
				
	217.	  	Wynne Garcia	  		  	
				
	218.	  	Yee Yang	  		  	
				
	219.	  	Tau Aroha Kaili Grace	  		  	
				
	220.	  	Ariane Lodeiro Robinson	  		  	
				
	221.	  	Bernie Lui	  		  	
				
	222.	  	Brett McConnie	  		  	
				
	223.	  	Chaitanya Chigurupati	  		  	
				
	224.	  	Christian Hewitt	  		  	
				
	225.	  	Chandra Kachana	  		  	
				
	226.	  	Daniel Rach	  		  	
				
	227.	  	Dungston Tharmaseelan	  		  	
				
	228.	  	Darren Tuer	  		  	
				
	229.	  	Dale Ware	  		  	
				
	230.	  	Francis Torres	  		  	
				
	231.	  	Gavin Gyles	  		  	
				
	232.	  	Herbert Gora	  		  	
				
	233.	  	Hemaben Panchal	  		  	

  
 page 13 

							
	 No.
	  	 Holder
	  	 Address
	  	 Email Address

				
	234.	  	Ilona Lazareva	  		  	
				
	235.	  	Johannes Baumbach	  		  	
				
	236.	  	Jarrad Beard	  		  	
				
	237.	  	Jay Buenvenida	  		  	
				
	238.	  	John Cotterill	  		  	
				
	239.	  	Jan Sapper	  		  	
				
	240.	  	Jagjit Singh	  		  	
				
	241.	  	Jeremy Street-Thomas	  		  	
				
	242.	  	Jakub Tkaczyk	  		  	
				
	243.	  	Jarrod Tuxworth	  		  	
				
	244.	  	Jarryn Wise	  		  	
				
	245.	  	Kelley Mann	  		  	
				
	246.	  	Kevin Van Der Donk	  		  	
				
	247.	  	Lekshmy Girija Jayakumar	  		  	
				
	248.	  	Leslie Smith	  		  	
				
	249.	  	Mathew Fox	  		  	
				
	250.	  	Muhammad Hamza	  		  	
				
	251.	  	Nathan Dunlop	  		  	

  
 page 14 

							
	 No.
	  	 Holder
	  	 Address
	  	 Email Address

				
	252.	  	Natalia Figueroa Sanchez	  		  	
				
	253.	  	Prakash Devaraj	  		  	
				
	254.	  	Phonechareun Ngo	  		  	
				
	255.	  	Patrick Smith	  		  	
				
	256.	  	Renee Healy	  		  	
				
	257.	  	Ryan Lonergan	  		  	
				
	258.	  	Richard Maclean	  		  	
				
	259.	  	Roy Phillips	  		  	
				
	260.	  	Raaj Sahdev	  		  	
				
	261.	  	Satish Kumar	  		  	
				
	262.	  	Sworoba Oyet Kep	  		  	
				
	263.	  	Steven Taylor	  		  	
				
	264.	  	St John Marsden	  		  	
				
	265.	  	Travis Howse	  		  	
				
	266.	  	Theresa Ramsey	  		  	
				
	267.	  	Umer Farooq	  		  	
				
	268.	  	Vincent De Denus	  		  	
				
	269.	  	Vivien Wei Ping Wong	  		  	
				
	270.	  	Yolanda Barber	  		  	

  
 page 15 

							
	 No.
	  	 Holder
	  	 Address
	  	 Email Address

				
	271.	  	Yogendrasinh Chauhan	  		  	
				
	272.	  	Yifan Yu	  		  	
				
	273.	  	Zhitao Liu	  		  	
				
	274.	  	Bernardo Blanco Uribe Sosa	  		  	
				
	275.	  	Brice Fallon-Freeman	  		  	
				
	276.	  	Bartosz Janiszewski	  		  	
				
	277.	  	Binil Karakunnel Jose	  		  	
				
	278.	  	Byung Ho Min	  		  	
				
	279.	  	Ba Vuong Tran	  		  	
				
	280.	  	Clint Newdick	  		  	
				
	281.	  	Daryl Moon	  		  	
				
	282.	  	Dane Muldoon	  		  	
				
	283.	  	Eischwar Preet Singh Grewal	  		  	
				
	284.	  	Elizabeth Williams	  		  	
				
	285.	  	Gareth Taylor	  		  	
				
	286.	  	Gioan Tran	  		  	
				
	287.	  	Ismail Yasik	  		  	
				
	288.	  	Julian Davis	  		  	

  
 page 16 

									
	 No.
	  	 Holder
	  	 Address
	  	 Email Address

				
	289.	  	James Mulliss	  		  	
				
	290.	  	Jackie O’Hagan	  		  	
				
	291.	  	Jimmy Yuk Ong Ting	  		  	
				
	292.	  	John Kennedy	  		  	
				
	293.	  	Katherine Van Der Meer	  		  	
				
	294.	  	Mitchell Burling	  		  	
				
	295.	  	Meena Kumari	  		  	
				
	296.	  	Michael Larcombe	  		  	
				
	297.	  	Matthew Smith	  		  	
				
	298.	  	Pierre Jordaan	  		  	
				
	299.	  	Richard Luce	  		  	
				
	300.	  	Shane Atkinson	  		  	
				
	301.	  	Salpadoru Thuppahige Chamara Udayangana	  		  	
				
	302.	  	Wayne Jenkins	  		  	
				
	303.	  	Fergus O’Donnell	  		  	
				
	304.	  	Jason Sinokula	  		  	
					
	305.	  	Raluca Strugaru	  		  		  	
				
	306.	  	Jarrod Wilson	  		  	

  
 page 17 

							
	 No.
	  	 Holder
	  	 Address
	  	 Email Address

				
	307.	  	Kararaina Kopa	  		  	
				
	308.	  	MD Al Amin	  		  	
				
	309.	  	Justin Russom	  		  	

  
 page 18

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00338-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00338-of-00352.parquet"}]]